Activation	O
of	O
primary	B-cell_type
human	I-cell_type
T-lymphocytes	I-cell_type
through	O
CD2	B-protein
plus	I-protein
CD28	I-protein
adhesion	I-protein
molecules	I-protein
induces	O
long-term	O
nuclear	O
expression	O
of	O
NF-kappa	B-protein
B	I-protein
.	O

Stimulation	O
of	O
highly	B-cell_type
purified	I-cell_type
human	I-cell_type
T-cells	I-cell_type
via	O
CD2	B-protein
and	I-protein
CD28	I-protein
adhesion	I-protein
molecules	I-protein
induces	O
and	O
maintains	O
proliferation	O
for	O
more	O
than	O
3	O
weeks	O
.	O

This	O
potent	O
interleukin	B-protein
2	I-protein
(	O
IL-2	B-protein
)	O
-dependent	O
activation	O
does	O
not	O
require	O
monocytes	B-cell_type
or	O
accessory	B-cell_type
cells	I-cell_type
.	O

Long-lasting	O
IL-2	B-protein
receptivity	O
is	O
associated	O
with	O
high-level	O
expression	O
of	O
the	O
inducible	O
IL-2	B-DNA
receptor	I-DNA
alpha	I-DNA
chain	I-DNA
(	I-DNA
IL-2R	I-DNA
alpha	I-DNA
)	I-DNA
gene	I-DNA
that	O
is	O
regulated	O
at	O
both	O
transcriptional	O
and	O
posttranscriptional	O
levels	O
.	O

Increase	O
of	O
IL-2R	B-DNA
alpha	I-DNA
gene	I-DNA
transcription	O
involves	O
the	O
enhanced	O
binding	O
of	O
the	O
transcription	O
factor	O
NF-kappa	B-protein
B	I-protein
to	O
its	O
consensus	B-DNA
sequence	I-DNA
in	O
the	O
5'-regulatory	B-DNA
region	I-DNA
of	O
the	O
IL-2R	B-DNA
alpha	I-DNA
gene	I-DNA
.	O

To	O
dissect	O
the	O
molecular	O
basis	O
for	O
the	O
unusually	O
persistent	O
transcription	O
of	O
the	O
IL-2R	B-DNA
alpha	I-DNA
gene	I-DNA
,	O
we	O
analyzed	O
nuclear	O
NF-kappa	B-protein
B	I-protein
binding	O
to	O
a	O
radiolabeled	O
IL-2R	B-protein
alpha	I-protein
kappa	O
B-specific	O
oligonucleotide	O
probe	O
during	O
the	O
time	O
course	O
of	O
CD2	B-protein
+	O
CD28	B-protein
activation	O
.	O

Resting	O
T-cell	O
nuclear	O
extracts	O
contained	O
KBF1/p50	B-protein
homodimer	I-protein
.	O

After	O
stimulation	O
,	O
two	O
new	O
kappa	B-protein
B-specific	I-protein
complexes	I-protein
were	O
identified	O
as	O
NF-kappa	B-protein
B	I-protein
p50-p65	B-protein
heterodimer	I-protein
and	O
putative	O
c-Rel	B-protein
homodimer	I-protein
or	O
c-Rel-p65	B-protein
heterodimer	I-protein
.	O

Both	O
inducible	O
complexes	O
persisted	O
for	O
at	O
least	O
3	O
weeks	O
.	O

Their	O
relative	O
levels	O
were	O
very	O
similar	O
for	O
the	O
duration	O
of	O
proliferation	O
.	O

In	O
parallel	O
,	O
CD2	B-protein
+	O
CD28	B-protein
activation	O
triggered	O
a	O
significant	O
intracellular	O
thiol	O
decrease	O
,	O
suggesting	O
that	O
oxygen	O
radicals	O
are	O
involved	O
in	O
the	O
signaling	O
pathway	O
of	O
adhesion	B-protein
molecules	I-protein
.	O

Finally	O
,	O
micromolar	O
amounts	O
of	O
pyrrolidine	O
dithiocarbamate	O
,	O
an	O
oxygen	O
radical	O
scavenger	O
that	O
efficiently	O
blocked	O
the	O
nuclear	O
appearance	O
of	O
NF-kappa	B-protein
B	I-protein
in	O
T-lymphocytes	B-cell_type
,	O
also	O
inhibited	O
IL-2	B-protein
secretion	O
,	O
IL-2R	B-protein
alpha	I-protein
cell	O
surface	O
expression	O
,	O
and	O
T-cell	O
proliferation	O
.	O

Together	O
,	O
these	O
results	O
suggest	O
that	O
NF-kappa	B-protein
B	I-protein
plays	O
an	O
important	O
role	O
in	O
long-term	O
activation	O
of	O
human	B-cell_type
primary	I-cell_type
T-lymphocytes	I-cell_type
via	O
CD2	B-protein
+	O
CD28	B-protein
.	O

Vol	NULL
.	NULL

4	NULL
,	NULL
329-339	NULL
,	NULL
April	NULL
1993	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
329	NULL
Activation	NULL
of	NULL
Primary	NULL
Human	NULL
T-Lymphocytes	NULL
through	NULL
CD2	NULL
Plus	NULL
CD28	NULL
Adhesion	NULL
Molecules	NULL
Induces	NULL
Long-Term	NULL
Nuclear	NULL
Expression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
'	NULL
Régis	NULL
Costello	NULL
,	NULL
Carol	NULL
Lipcey	NULL
,	NULL
Michele	NULL
Algarté	NULL
,	NULL
Chantal	NULL
Cerdan	NULL
,	NULL
Patrick	NULL
A.	NULL
Baeuerle	NULL
,	NULL
Daniel	NULL
Olive	NULL
,	NULL
and	NULL
Jean	NULL
Imbert	NULL
Unité	NULL
119	NULL
,	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
,	NULL
27	NULL
,	NULL
Boulevard	NULL
Lei	NULL
Roure	NULL
,	NULL
13009	NULL
Marseille	NULL
,	NULL
France	NULL
[	NULL
R.	NULL
C.	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
D.	NULL
O.	NULL
,	NULL
J	NULL
.	NULL

I	NULL
.	NULL
]	NULL

,	NULL
and	NULL
Laboratorium	NULL
fir	NULL
Molekulare	NULL
Biologie	NULL
,	NULL
Ludwig-Maximilians-Universitat	NULL
,	NULL
Genzentrum	NULL
,	NULL
D-8033	NULL
Martinsried	NULL
,	NULL
Germany	NULL
[	NULL
P.	NULL
A	NULL
.	NULL

B	NULL
.	NULL
]	NULL

Abstract	NULL
Stimulation	NULL
of	NULL
highly	NULL
purified	NULL
human	NULL
T-cells	NULL
via	NULL
CD2	NULL
and	NULL
CD28	NULL
adhesion	NULL
molecules	NULL
induces	NULL
and	NULL
maintains	NULL
proliferation	NULL
for	NULL
more	NULL
than	NULL
3	NULL
weeks	NULL
.	NULL

This	NULL
potent	NULL
interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
-dependent	NULL
activation	NULL
does	NULL
not	NULL
require	NULL
monocytes	NULL
or	NULL
accessory	NULL
cells	NULL
.	NULL

Long-lasting	NULL
IL-2	NULL
receptivity	NULL
is	NULL
associated	NULL
with	NULL
high-level	NULL
expression	NULL
of	NULL
the	NULL
inducible	NULL
IL-2	NULL
receptor	NULL
a	NULL
chain	NULL
(	NULL
/L-2Ra	NULL
)	NULL
gene	NULL
that	NULL
is	NULL
regulated	NULL
at	NULL
both	NULL
transcriptional	NULL
and	NULL
posttranscriptional	NULL
levels	NULL
.	NULL

Increase	NULL
of	NULL
IL-2Ra	NULL
gene	NULL
transcription	NULL
involves	NULL
the	NULL
enhanced	NULL
binding	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
its	NULL
consensus	NULL
sequence	NULL
in	NULL
the	NULL
5'-regulatory	NULL
region	NULL
of	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
.	NULL

To	NULL
dissect	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
unusually	NULL
persistent	NULL
transcription	NULL
of	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
,	NULL
we	NULL
analyzed	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
to	NULL
a	NULL
radiolabeled	NULL
IL-2Ra	NULL
«	NULL
B-specific	NULL
oligonucleotide	NULL
probe	NULL
during	NULL
the	NULL
time	NULL
course	NULL
of	NULL
CD24+CD28	NULL
activation	NULL
.	NULL

Resting	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
contained	NULL
KBF1/p50	NULL
homodimer	NULL
.	NULL

After	NULL
stimulation	NULL
,	NULL
two	NULL
new	NULL
«	NULL
B-specific	NULL
complexes	NULL
were	NULL
identified	NULL
as	NULL
NF-	NULL
«	NULL
B	NULL
p50-p65	NULL
heterodimer	NULL
and	NULL
putative	NULL
c-Rel	NULL
homodimer	NULL
or	NULL
c-Rel-p65	NULL
heterodimer	NULL
.	NULL

Both	NULL
inducible	NULL
complexes	NULL
persisted	NULL
for	NULL
at	NULL
least	NULL
3	NULL
weeks	NULL
.	NULL

Their	NULL
relative	NULL
levels	NULL
were	NULL
very	NULL
similar	NULL
for	NULL
the	NULL
duration	NULL
of	NULL
proliferation	NULL
.	NULL

In	NULL
parallel	NULL
,	NULL
CD2+CD28	NULL
activation	NULL
triggered	NULL
a	NULL
significant	NULL
intracellular	NULL
thiol	NULL
decrease	NULL
,	NULL
suggesting	NULL
that	NULL
oxygen	NULL
radicals	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
signaling	NULL
pathway	NULL
of	NULL
adhesion	NULL
molecules	NULL
.	NULL

Finally	NULL
,	NULL
micromolar	NULL
amounts	NULL
of	NULL
pyrrolidine	NULL
dithiocarbamate	NULL
,	NULL
an	NULL
oxygen	NULL
radical	NULL
scavenger	NULL
that	NULL
efficiently	NULL
blocked	NULL
the	NULL
nuclear	NULL
appearance	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
T-lymphocytes	NULL
,	NULL
also	NULL
inhibited	NULL
IL-2	NULL
secretion	NULL
,	NULL
IL-2Ra	NULL
cell	NULL
surface	NULL
expression	NULL
,	NULL
and	NULL
T-cell	NULL
proliferation	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
long-term	NULL
activation	NULL
of	NULL
human	NULL
primary	NULL
T-lymphocytes	NULL
via	NULL
CD2+CD28	NULL
.	NULL

Received	NULL
11/25/92	NULL
;	NULL
revised	NULL
1/12/93	NULL
;	NULL
accepted	NULL
1/22/93	NULL
.	NULL
'	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
and	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Association	NULL
pour	NULL
la	NULL
Recherche	NULL
sur	NULL
le	NULL
Cancer	NULL
,	NULL
awarded	NULL
to	NULL
J.	NULL
Imbert	NULL
and	NULL
D.	NULL
Olive	NULL
,	NULL
and	NULL
partially	NULL
fulfills	NULL
the	NULL
requirements	NULL
for	NULL
the	NULL
doctoral	NULL
thesis	NULL
of	NULL
R.	NULL
Costello	NULL
and	NULL
M.	NULL
Algarté	NULL
.	NULL

*	NULL
To	NULL
whom	NULL
requests	NULL
for	NULL
reprints	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Introduction	NULL
In	NULL
vitro	NULL
,	NULL
T-lymphocyte	NULL
activation	NULL
requires	NULL
combined	NULL
action	NULL
of	NULL
two	NULL
signals	NULL
provided	NULL
by	NULL
different	NULL
combinations	NULL
of	NULL
lectins	NULL
,	NULL
phorbol	NULL
esters	NULL
,	NULL
cytokines	NULL
,	NULL
or	NULL
mAbs	NULL
.	NULL
``	NULL

Two	NULL
main	NULL
activation	NULL
pathways	NULL
have	NULL
been	NULL
described	NULL
:	NULL
the	NULL
antigen-dependent	NULL
pathway	NULL
,	NULL
involving	NULL
the	NULL
CD3/TcR	NULL
complex	NULL
,	NULL
and	NULL
the	NULL
adhesion	NULL
molecule	NULL
pathway	NULL
,	NULL
engaging	NULL
CD2	NULL
and	NULL
CD28	NULL
surface	NULL
molecules	NULL
.	NULL

CD2	NULL
,	NULL
first	NULL
described	NULL
as	NULL
the	NULL
sheep	NULL
erythrocyte	NULL
receptor	NULL
,	NULL
is	NULL
present	NULL
on	NULL
nearly	NULL
all	NULL
T-lymphocytes	NULL
.	NULL

Its	NULL
major	NULL
natural	NULL
ligand	NULL
,	NULL
the	NULL
lymphocyte	NULL
function	NULL
associated	NULL
3	NULL
surface	NULL
molecule	NULL
,	NULL
is	NULL
of	NULL
wide	NULL
cellular	NULL
and	NULL
tissular	NULL
distribution	NULL
(	NULL
1	NULL
)	NULL
.	NULL

CD28	NULL
molecule	NULL
is	NULL
present	NULL
on	NULL
only	NULL
half	NULL
of	NULL
the	NULL
CD8-positive	NULL
resting	NULL
T-cells	NULL
but	NULL
on	NULL
almost	NULL
all	NULL
of	NULL
the	NULL
CD4-positive	NULL
cells	NULL
(	NULL
2	NULL
)	NULL
.	NULL

CD28	NULL
shares	NULL
with	NULL
CTLA-4	NULL
its	NULL
ligand	NULL
B7/BB1	NULL
.	NULL

B7/BB1	NULL
has	NULL
a	NULL
more	NULL
restricted	NULL
distri-bution	NULL
,	NULL
since	NULL
it	NULL
is	NULL
expressed	NULL
only	NULL
on	NULL
activated	NULL
T-lymphocytes	NULL
,	NULL
y-interferon-treated	NULL
monocytes	NULL
,	NULL
and	NULL
mouse	NULL
den-dritic	NULL
thymic	NULL
cells	NULL
(	NULL
3-5	NULL
)	NULL
.	NULL

Both	NULL
pathways	NULL
can	NULL
be	NULL
mimicked	NULL
by	NULL
in	NULL
vitro	NULL
use	NULL
of	NULL
mAbs	NULL
directed	NULL
against	NULL
these	NULL
molecules	NULL
(	NULL
6-10	NULL
)	NULL
.	NULL

Simultaneous	NULL
activation	NULL
of	NULL
CD2	NULL
and	NULL
CD28	NULL
leads	NULL
to	NULL
a	NULL
long-lasting	NULL
proliferation	NULL
(	NULL
>	NULL
3	NULL
weeks	NULL
versus	NULL
10	NULL
days	NULL
for	NULL
the	NULL
CD3/TcR	NULL
pathway	NULL
)	NULL
of	NULL
highly	NULL
purified	NULL
human	NULL
T-lymphocytes	NULL
(	NULL
11	NULL
)	NULL
.	NULL

CD2+CD28-triggered	NULL
proliferation	NULL
does	NULL
not	NULL
require	NULL
the	NULL
presence	NULL
of	NULL
monocytes	NULL
or	NULL
accessory	NULL
cells	NULL
but	NULL
depends	NULL
strongly	NULL
on	NULL
IL-2	NULL
secretion	NULL
by	NULL
the	NULL
T-cells	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

This	NULL
long-lasting	NULL
,	NULL
IL-2-dependent	NULL
autocrine	NULL
or	NULL
paracrine	NULL
proliferation	NULL
is	NULL
apparently	NULL
sustained	NULL
by	NULL
a	NULL
persistent	NULL
high-level	NULL
expression	NULL
of	NULL
its	NULL
high-affinity	NULL
receptor	NULL
.	NULL

Following	NULL
CD2+CD28	NULL
costimulation	NULL
,	NULL
and	NULL
/L-2Ra	NULL
genes	NULL
are	NULL
differentially	NULL
regulated	NULL
at	NULL
both	NULL
the	NULL
transcriptional	NULL
and	NULL
posttranscriptional	NULL
levels	NULL
(	NULL
11-14	NULL
)	NULL
.	NULL

Several	NULL
constitutive	NULL
and	NULL
inducible	NULL
cis-acting	NULL
regulatory	NULL
sequences	NULL
and	NULL
trans-acting	NULL
factors	NULL
involved	NULL
in	NULL
their	NULL
regulation	NULL
have	NULL
now	NULL
been	NULL
identified	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

15	NULL
)	NULL
.	NULL

Among	NULL
the	NULL
inducible	NULL
factors	NULL
,	NULL
recent	NULL
attention	NULL
has	NULL
focused	NULL
on	NULL
the	NULL
role	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
T-cell	NULL
growth	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

16	NULL
)	NULL
.	NULL

T-cells	NULL
stimulated	NULL
by	NULL
various	NULL
stimuli	NULL
activate	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
and	NULL
related	NULL
proteins	NULL
involved	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
and	NULL
/L-2Ra	NULL
genes	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
,	NULL
identified	NULL
originally	NULL
as	NULL
an	NULL
immunoglobulin	NULL
x	NULL
light	NULL
chain	NULL
enhancer-binding	NULL
complex	NULL
(	NULL
17	NULL
)	NULL
,	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
a	NULL
large	NULL
number	NULL
of	NULL
genes	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

18	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
is	NULL
a	NULL
member	NULL
of	NULL
a	NULL
novel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
including	NULL
the	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
mAb	NULL
,	NULL
monoclonal	NULL
antibody	NULL
;	NULL
iL-2	NULL
,	NULL
interleukin	NULL
2	NULL
;	NULL
-R	NULL
,	NULL
receptor	NULL
;	NULL
PMA	NULL
,	NULL
46-phorbol	NULL
12-myristate	NULL
13a-acetate	NULL
;	NULL
NF	NULL
,	NULL
nuclear	NULL
factor	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
PDTC	NULL
,	NULL
pyrrolidine	NULL
dithiocarbamate	NULL
;	NULL
ROI	NULL
,	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
;	NULL
PHA	NULL
,	NULL
phytohemag-glutinin	NULL
;	NULL
kDa	NULL
,	NULL
kilodalton	NULL
(	NULL
s	NULL
}	NULL
;	NULL
TNF-a	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
;	NULL
TPA	NULL
,	NULL
12-O-tetradecanoylphorbol-13-acetate	NULL
;	NULL
GM-CSF	NULL
,	NULL
-	NULL
granulocyte/macrophage-colony-stimulating	NULL
factor	NULL
;	NULL
ELISA	NULL
,	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
;	NULL
MCB	NULL
,	NULL
monochlorobimane	NULL
.	NULL

330	NULL
-	NULL
NF-	NULL
«	NULL
B	NULL
Activation	NULL
in	NULL
CD2+CD28-stimulated	NULL
Primary	NULL
T-Cells	NULL
subunits	NULL
p50	NULL
and	NULL
p65	NULL
,	NULL
c-Rel	NULL
,	NULL
p49/p100	NULL
,	NULL
and	NULL
1-Rel	NULL
(	NULL
for	NULL
reviews	NULL
,	NULL
see	NULL
Refs	NULL
.	NULL

19	NULL
and	NULL
20	NULL
)	NULL
.	NULL

The	NULL
amino-terminal	NULL
portions	NULL
of	NULL
these	NULL
proteins	NULL
also	NULL
share	NULL
amino	NULL
acid	NULL
sequence	NULL
homology	NULL
with	NULL
the	NULL
product	NULL
of	NULL
the	NULL
morphogen	NULL
dorsal	NULL
gene	NULL
from	NULL
Drosophila	NULL
melanogaster	NULL
.	NULL

The	NULL
homology	NULL
domain	NULL
was	NULL
shown	NULL
to	NULL
encompass	NULL
dimerization	NULL
,	NULL
nuclear	NULL
targeting	NULL
,	NULL
and	NULL
DNA	NULL
and	NULL
IkB	NULL
binding	NULL
domains	NULL
.	NULL

With	NULL
respect	NULL
to	NULL
the	NULL
adhesion	NULL
molecule	NULL
pathway	NULL
,	NULL
a	NULL
transcription	NULL
study	NULL
in	NULL
Jurkat	NULL
T-cells	NULL
has	NULL
demonstrated	NULL
that	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
of	NULL
the	NULL
human	NULL
immunodefi-ciency	NULL
virus	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
are	NULL
required	NULL
for	NULL
signaling	NULL
by	NULL
CD28	NULL
(	NULL
21	NULL
)	NULL
.	NULL

in	NULL
vitro	NULL
binding	NULL
studies	NULL
using	NULL
Jurkat	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
have	NULL
demonstrated	NULL
that	NULL
CD28-induced	NULL
signal	NULL
synergizes	NULL
with	NULL
either	NULL
PMA	NULL
or	NULL
CD3	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
nuclear	NULL
factors	NULL
that	NULL
bind	NULL
CD28RE	NULL
,	NULL
a	NULL
«	NULL
B-like	NULL
motif	NULL
of	NULL
the	NULL
IL-2	NULL
enhancer	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
PMA-activated	NULL
Jurkat	NULL
T-cells	NULL
produce	NULL
two	NULL
distinct	NULL
complexes	NULL
in	NULL
EMSAs	NULL
when	NULL
incubated	NULL
with	NULL
the	NULL
«	NULL
B	NULL
element	NULL
from	NULL
the	NULL
/L-2Ra	NULL
gene	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Following	NULL
activation	NULL
,	NULL
nuclear	NULL
appearance	NULL
of	NULL
these	NULL
proteins	NULL
is	NULL
induced	NULL
with	NULL
distinct	NULL
biphasic	NULL
kinetics	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
T-lymphocyte	NULL
gene	NULL
activation	NULL
program	NULL
might	NULL
involve	NULL
modulation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
subunit	NULL
composition	NULL
.	NULL

A	NULL
recent	NULL
report	NULL
has	NULL
shown	NULL
that	NULL
the	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
activated	NULL
by	NULL
binding	NULL
of	NULL
IL-2	NULL
to	NULL
its	NULL
receptor	NULL
in	NULL
purified	NULL
primary	NULL
resting	NULL
human	NULL
T-cells	NULL
(	NULL
23	NULL
)	NULL
.	NULL

However	NULL
,	NULL
to	NULL
date	NULL
,	NULL
no	NULL
study	NULL
has	NULL
addressed	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
human	NULL
purified	NULL
T-lymphocytes	NULL
activated	NULL
via	NULL
the	NULL
adhesion	NULL
molecules	NULL
CD2	NULL
and	NULL
CD28	NULL
.	NULL

Rapid	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
activity	NULL
is	NULL
regulated	NULL
at	NULL
a	NULL
posttranscriptional	NULL
level	NULL
,	NULL
involving	NULL
the	NULL
release	NULL
of	NULL
an	NULL
inhibitory	NULL
factor	NULL
,	NULL
I	NULL
«	NULL
B	NULL
,	NULL
from	NULL
a	NULL
preformed	NULL
cytoplasmic	NULL
protein	NULL
complex	NULL
.	NULL

in	NULL
vitro	NULL
,	NULL
dissociation	NULL
can	NULL
be	NULL
triggered	NULL
by	NULL
treatment	NULL
with	NULL
detergent	NULL
,	NULL
low	NULL
pH	NULL
,	NULL
protein	NULL
kinases	NULL
,	NULL
and	NULL
protein	NULL
phosphatases	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

24	NULL
)	NULL
.	NULL

The	NULL
modification	NULL
releasing	NULL
I	NULL
«	NULL
B	NULL
in	NULL
the	NULL
intact	NULL
cell	NULL
is	NULL
not	NULL
known	NULL
but	NULL
is	NULL
likely	NULL
to	NULL
involve	NULL
phosphorylation	NULL
events	NULL
.	NULL

Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
triggered	NULL
by	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
mostly	NULL
pathogenic	NULL
agents	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

18	NULL
)	NULL
.	NULL

In	NULL
T-cells	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
macrophages	NULL
and	NULL
monocytes	NULL
,	NULL
for	NULL
instance	NULL
,	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
activating	NULL
signals	NULL
are	NULL
mitogenic	NULL
and	NULL
encompass	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
phorbol	NULL
ester	NULL
,	NULL
lectins	NULL
,	NULL
antigen	NULL
,	NULL
monoclonal	NULL
antibodies	NULL
,	NULL
and	NULL
infection	NULL
with	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
.	NULL

Various	NULL
genes	NULL
encoding	NULL
IxB	NULL
proteins	NULL
have	NULL
been	NULL
cloned	NULL
,	NULL
including	NULL
MAD-3	NULL
(	NULL
25	NULL
)	NULL
,	NULL
pp40	NULL
(	NULL
26	NULL
)	NULL
,	NULL
bei-3	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
,	NULL
IkBy	NULL
(	NULL
29	NULL
)	NULL
,	NULL
and	NULL
RF/IF-1	NULL
(	NULL
30	NULL
)	NULL
.	NULL

I	NULL
«	NULL
B-like	NULL
proteins	NULL
contain	NULL
an	NULL
ankyrin-like	NULL
repeat	NULL
domain	NULL
also	NULL
found	NULL
in	NULL
the	NULL
carboxy-terminal	NULL
part	NULL
of	NULL
the	NULL
p105	NULL
and	NULL
p100	NULL
precursors	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
and	NULL
p49	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

20	NULL
)	NULL
.	NULL

The	NULL
ankyrin	NULL
repeat	NULL
is	NULL
apparently	NULL
involved	NULL
in	NULL
complex	NULL
formation	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
by	NULL
contacting	NULL
the	NULL
rel	NULL
homology	NULL
domain	NULL
.	NULL

IxB-like	NULL
factors	NULL
display	NULL
distinct	NULL
affinity	NULL
in	NULL
vitro	NULL
for	NULL
NF-	NULL
«	NULL
B/Rel	NULL
complexes	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Several	NULL
recent	NULL
studies	NULL
indicate	NULL
that	NULL
distinct	NULL
combinations	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
could	NULL
determine	NULL
the	NULL
specificity	NULL
of	NULL
transcriptional	NULL
activation	NULL
through	NULL
modulation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
to	NULL
the	NULL
various	NULL
«	NULL
B	NULL
motifs	NULL
(	NULL
20	NULL
,	NULL
32-34	NULL
)	NULL
.	NULL

The	NULL
availability	NULL
of	NULL
inhibitor	NULL
and	NULL
activator	NULL
subunits	NULL
allows	NULL
separation	NULL
of	NULL
functions	NULL
in	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

This	NULL
may	NULL
explain	NULL
the	NULL
apparent	NULL
paradox	NULL
between	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
many	NULL
inducers	NULL
,	NULL
on	NULL
one	NULL
hand	NULL
,	NULL
and	NULL
the	NULL
specificity	NULL
of	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
,	NULL
on	NULL
the	NULL
other	NULL
.	NULL

Parant	NULL
ranmrte	NULL
havo	NULL
chum	NULL
that	NULL
arctivatinn	NULL
hy	NULL
by	NULL
compounds	NULL
such	NULL
as	NULL
L-cysteine	NULL
,	NULL
N-acetyl	NULL
--	NULL
cysteine	NULL
,	NULL
or	NULL
PDTC	NULL
(	NULL
35-38	NULL
)	NULL
.	NULL

The	NULL
chemical	NULL
basis	NULL
for	NULL
cysteine	NULL
and	NULL
PDTC	NULL
inhibiting	NULL
effects	NULL
seemed	NULL
to	NULL
lie	NULL
in	NULL
the	NULL
oxygen	NULL
radical-scavenging	NULL
activity	NULL
of	NULL
sulfur-containing	NULL
groups	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
ROI	NULL
are	NULL
important	NULL
and	NULL
widely	NULL
used	NULL
messengers	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
36	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
our	NULL
precise	NULL
knowledge	NULL
about	NULL
NF-	NULL
«	NULL
B	NULL
structure	NULL
and	NULL
interaction	NULL
with	NULL
I	NULL
«	NULL
kB	NULL
and	NULL
enhancer	NULL
ele-ments	NULL
,	NULL
only	NULL
a	NULL
few	NULL
studies	NULL
have	NULL
assessed	NULL
its	NULL
physiological	NULL
role	NULL
in	NULL
primary	NULL
human	NULL
T-cells	NULL
(	NULL
23	NULL
,	NULL
39-41	NULL
)	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
role	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
adhesion	NULL
molecule	NULL
activation	NULL
as	NULL
mimicked	NULL
by	NULL
anti-CD2	NULL
and	NULL
anti-CD28	NULL
treatment	NULL
of	NULL
purified	NULL
human	NULL
T-cells	NULL
.	NULL

The	NULL
unique	NULL
long-term	NULL
T-cell	NULL
activation	NULL
induced	NULL
by	NULL
these	NULL
mAbs	NULL
(	NULL
9	NULL
,	NULL
11	NULL
,	NULL
42	NULL
,	NULL
43	NULL
)	NULL
was	NULL
further	NULL
characterized	NULL
in	NULL
terms	NULL
of	NULL
proliferation	NULL
,	NULL
IL-2	NULL
secretion	NULL
,	NULL
and	NULL
receptivity	NULL
.	NULL

In	NULL
parallel	NULL
,	NULL
an	NULL
EMSA	NULL
was	NULL
used	NULL
to	NULL
detect	NULL
NF-	NULL
«	NULL
B-related	NULL
complexes	NULL
present	NULL
in	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
CD2+CD28-activated	NULL
T-cells	NULL
,	NULL
and	NULL
the	NULL
different	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
members	NULL
were	NULL
identified	NULL
by	NULL
DNA-protein	NULL
UV-cross-linking	NULL
assays	NULL
and	NULL
NF-	NULL
«	NULL
B-specific	NULL
antisera	NULL
.	NULL

We	NULL
analyzed	NULL
the	NULL
effect	NULL
of	NULL
PDTC	NULL
,	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
to	NULL
evaluate	NULL
the	NULL
role	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
in	NULL
CD2+CD28-triggered	NULL
proliferation	NULL
and	NULL
cytokine	NULL
synthesis	NULL
.	NULL

Thiol	NULL
level	NULL
variations	NULL
were	NULL
determined	NULL
by	NULL
flow	NULL
cytometry	NULL
to	NULL
assess	NULL
the	NULL
involvement	NULL
of	NULL
ROI	NULL
in	NULL
the	NULL
onset	NULL
of	NULL
CD24+CD28	NULL
T-cell	NULL
activation	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
T-cell	NULL
activation	NULL
by	NULL
the	NULL
adhesion	NULL
molecule	NULL
pathway	NULL
leads	NULL
to	NULL
long-term	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

The	NULL
functional	NULL
significance	NULL
of	NULL
this	NULL
event	NULL
is	NULL
supported	NULL
by	NULL
pharmacological	NULL
experiments	NULL
with	NULL
an	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Finally	NULL
,	NULL
evidence	NULL
is	NULL
provided	NULL
that	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
appearance	NULL
relies	NULL
on	NULL
a	NULL
prooxidant	NULL
state	NULL
of	NULL
peripheral	NULL
T-cells	NULL
.	NULL

Results	NULL
Characterization	NULL
of	NULL
T-Lymphocyte	NULL
Activation	NULL
through	NULL
the	NULL
CD2/CD28	NULL
Adhesion	NULL
Molecule	NULL
Pathway	NULL
.	NULL

Purified	NULL
human	NULL
T-lymphocyte	NULL
activation	NULL
by	NULL
CD2	NULL
and	NULL
CD28	NULL
mAbs	NULL
was	NULL
characterized	NULL
in	NULL
terms	NULL
of	NULL
proliferation	NULL
,	NULL
IL-2	NULL
secretion	NULL
,	NULL
and	NULL
receptivity	NULL
.	NULL

The	NULL
T-cell	NULL
proliferation	NULL
rate	NULL
was	NULL
measured	NULL
by	NULL
incorporation	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Stimulation	NULL
with	NULL
CD28	NULL
mAb	NULL
associated	NULL
with	NULL
CD2	NULL
mAb	NULL
induced	NULL
high-level	NULL
proliferation	NULL
compared	NULL
to	NULL
the	NULL
CD3¢+CD28	NULL
combination	NULL
.	NULL

Both	NULL
proliferations	NULL
lasted	NULL
for	NULL
at	NULL
least	NULL
3	NULL
weeks	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
CD3¢	NULL
alone	NULL
triggered	NULL
stimulation	NULL
for	NULL
only	NULL
1	NULL
week	NULL
.	NULL

CD2	NULL
or	NULL
CD28	NULL
mAb	NULL
or	NULL
medium	NULL
alone	NULL
induced	NULL
no	NULL
or	NULL
very	NULL
little	NULL
(	NULL
<	NULL
1000	NULL
cpm	NULL
)	NULL
proliferation	NULL
.	NULL

CD2+CD28	NULL
costimulation	NULL
induced	NULL
a	NULL
higher	NULL
level	NULL
of	NULL
IL-2	NULL
secretion	NULL
than	NULL
CD3c+CD28	NULL
,	NULL
and	NULL
IL-2	NULL
remained	NULL
measurable	NULL
at	NULL
least	NULL
until	NULL
day	NULL
7	NULL
,	NULL
compared	NULL
to	NULL
day	NULL
4	NULL
for	NULL
CD3c+CD28	NULL
costimulation	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Cumulative	NULL
IL-2	NULL
secretion	NULL
was	NULL
2	NULL
times	NULL
higher	NULL
with	NULL
CD2+CD28	NULL
stimulus	NULL
than	NULL
CD3c+CD28	NULL
.	NULL

Single	NULL
stimulus	NULL
CD3c	NULL
,	NULL
CD2	NULL
,	NULL
CD28	NULL
,	NULL
or	NULL
medium	NULL
alone	NULL
did	NULL
not	NULL
induce	NULL
detectable	NULL
IL-2	NULL
secre-tion	NULL
.	NULL

-	NULL
Both	NULL
combined	NULL
stimuli	NULL
(	NULL
CD2+CD28	NULL
-	NULL
or	NULL
CD3c¢+CD28	NULL
)	NULL
induced	NULL
high-level	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
IL-2Ra	NULL
chain	NULL
,	NULL
reaching	NULL
80	NULL
and	NULL
83	NULL
%	NULL
of	NULL
positive	NULL
cells	NULL
,	NULL
respectively	NULL
,	NULL
at	NULL
6	NULL
days	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

However	NULL
,	NULL
CD2+CD28-induced	NULL
IL-2Ra	NULL
expression	NULL
persisted	NULL
for	NULL
at	NULL
least	NULL
3	NULL
weeks	NULL
as	NULL
opposed	NULL
to	NULL
that	NULL
of	NULL
CD3c¢+CD28	NULL
,	NULL
which	NULL
decreased	NULL
after	NULL
2	NULL
weeks	NULL
.	NULL

CD3¢	NULL
alone	NULL
induced	NULL
a	NULL
relatively	NULL
weaker	NULL
(	NULL
peak	NULL
,	NULL
53	NULL
%	NULL
)	NULL
and	NULL
shorter	NULL
IL-2Ra	NULL
expression	NULL
(	NULL
<	NULL
10	NULL
days	NULL
)	NULL
.	NULL

Ac	NULL
tho	NULL
cnluhlo	NULL
II	NULL
R	NULL
rhain	NULL
can	NULL
hind	NULL
ta	NULL
H	NULL
_	NULL
?	NULL

thaorahw	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
331	NULL
PROLIFERATION	NULL
002	NULL
40	NULL
8	NULL
8	NULL
fo	NULL
12	NULL
14	NULL
1s	NULL
18	NULL
20	NULL
TIME	NULL
(	NULL
days	NULL
)	NULL
CD25	NULL
EXPRESSION	NULL
100	NULL
C	NULL
%	NULL
POSITIVE	NULL
CELLS	NULL
0	NULL
2	NULL
4	NULL
6	NULL
8	NULL
10	NULL
12	NULL
14	NULL
16	NULL
18	NULL
20	NULL
TIME	NULL
(	NULL
days	NULL
)	NULL
IL-2	NULL
SECRETION	NULL
£	NULL
8	NULL
o	NULL
€	NULL
pj	NULL
a	NULL
€	NULL
u	NULL
2	NULL
PJ	NULL
a	NULL
0	NULL
0.1260.25	NULL
10	NULL
2	NULL
o	NULL
4	NULL
0	NULL
To	NULL
oue	NULL
rl	NULL
TIME	NULL
(	NULL
days	NULL
)	NULL
SOLUBLE	NULL
IL-2	NULL
RECEPTOR	NULL
HF	NULL
0	NULL
©	NULL
|	NULL
©	NULL
uf	NULL
2	NULL
3	NULL
G	NULL
00	NULL
r	NULL
4	NULL
8	NULL
O8	NULL
fo	NULL
12	NULL
14	NULL
16	NULL
18	NULL
20	NULL
TIME	NULL
(	NULL
days	NULL
)	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Characterization	NULL
of	NULL
CD2+CD28	NULL
costimulation	NULL
of	NULL
purified	NULL
human	NULL
T-lymphocytes	NULL
compared	NULL
to	NULL
CD3¢	NULL
and	NULL
CD3¢+CD28	NULL
stimulations	NULL
.	NULL

Stimulations	NULL
were	NULL
performed	NULL
with	NULL
different	NULL
mAbs	NULL
used	NULL
at	NULL
saturating	NULL
concentrations	NULL
:	NULL
CD2	NULL
mAb	NULL
39C1.5	NULL
and	NULL
6F10.3	NULL
;	NULL
CD3¢	NULL
mAb	NULL
289	NULL
.	NULL

Total	NULL
cell	NULL
numbers	NULL
were	NULL
counted	NULL
microscopically	NULL
by	NULL
phase	NULL
contrast	NULL
,	NULL
and	NULL
the	NULL
number	NULL
of	NULL
dead	NULL
cells	NULL
was	NULL
determined	NULL
by	NULL
trypan	NULL
blue	NULL
uptake	NULL
.	NULL

A	NULL
,	NULL
proliferative	NULL
response	NULL
from	NULL
day	NULL
2	NULL
to	NULL
day	NULL
21	NULL
poststimulation	NULL
.	NULL

Each	NULL
value	NULL
corresponds	NULL
to	NULL
[	NULL
H	NULL
]	NULL
thymidine	NULL
incorporation	NULL
for	NULL
18	NULL
h	NULL
in	NULL
20,000	NULL
cells	NULL
.	NULL

B	NULL
,	NULL
ELISA	NULL
assay	NULL
titration	NULL
of	NULL
IL-2	NULL
secretion	NULL
was	NULL
measured	NULL
as	NULL
pg/ml	NULL
and	NULL
converted	NULL
to	NULL
pg/10®	NULL
seeded	NULL
cells	NULL
.	NULL

C	NULL
,	NULL
percentage	NULL
of	NULL
cells	NULL
expressing	NULL
CD25/IL-2Ra	NULL
was	NULL
determined	NULL
on	NULL
5,000	NULL
cell	NULL
samples	NULL
using	NULL
a	NULL
FACSCAN	NULL
{	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

D	NULL
,	NULL
ELISA	NULL
assay	NULL
titration	NULL
of	NULL
soluble	NULL
IL-2	NULL
receptor	NULL
release	NULL
was	NULL
measured	NULL
as	NULL
pg/ml	NULL
and	NULL
converted	NULL
to	NULL
pg/10®	NULL
seeded	NULL
cells	NULL
.	NULL

Each	NULL
pane	NULL
!	NULL

shows	NULL
the	NULL
results	NULL
of	NULL
one	NULL
representative	NULL
experiment	NULL
of	NULL
two	NULL
and	NULL
corresponds	NULL
to	NULL
phenotypic	NULL
analysis	NULL
performed	NULL
in	NULL
parallel	NULL
with	NULL
the	NULL
same	NULL
batch	NULL
of	NULL
stimulated	NULL
cells	NULL
.	NULL

0	NULL
,	NULL
CD2+CD28	NULL
;	NULL
@	NULL
,	NULL
CD3c+CD28	NULL
;	NULL
@	NULL
,	NULL
CD3c	NULL
.	NULL

the	NULL
levels	NULL
of	NULL
IL-2Ra	NULL
chain	NULL
cellular	NULL
release	NULL
after	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

1D	NULL
)	NULL
.	NULL

CD2+CD28	NULL
or	NULL
CD3¢+CD28	NULL
combination	NULL
induced	NULL
high	NULL
levels	NULL
of	NULL
soluble	NULL
IL-2	NULL
receptor	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
CD3c	NULL
alone	NULL
.	NULL

Both	NULL
combined	NULL
stimuli	NULL
induced	NULL
comparable	NULL
total	NULL
amounts	NULL
of	NULL
soluble	NULL
IL-2	NULL
receptor	NULL
,	NULL
with	NULL
higher	NULL
levels	NULL
for	NULL
CD3¢+CD28	NULL
at	NULL
14	NULL
days	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
CD2	NULL
and	NULL
CD28	NULL
costimulation	NULL
induced	NULL
a	NULL
long-lasting	NULL
proliferation	NULL
of	NULL
primary	NULL
T-cell	NULL
culture	NULL
for	NULL
up	NULL
to	NULL
3	NULL
weeks	NULL
.	NULL

In	NULL
sharp	NULL
contrast	NULL
,	NULL
CD3¢	NULL
alone	NULL
and	NULL
other	NULL
stimuli	NULL
,	NULL
such	NULL
as	NULL
PHA+1IL-2	NULL
or	NULL
PHA+PMA	NULL
,	NULL
support	NULL
at	NULL
best	NULL
1-week-long	NULL
proliferation	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
demonstrated	NULL
that	NULL
following	NULL
activation	NULL
,	NULL
IL-2Ra	NULL
chains	NULL
released	NULL
from	NULL
the	NULL
membrane	NULL
could	NULL
bind	NULL
IL-2	NULL
efficiently	NULL
and	NULL
inhibit	NULL
IL-2	NULL
cellular	NULL
uptake	NULL
(	NULL
44	NULL
,	NULL
45	NULL
)	NULL
.	NULL

We	NULL
do	NULL
not	NULL
believe	NULL
that	NULL
these	NULL
observations	NULL
are	NULL
of	NULL
relevance	NULL
for	NULL
the	NULL
IL-2-dependent	NULL
CD2+CD28	NULL
stimulation	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
,	NULL
since	NULL
high	NULL
levels	NULL
of	NULL
soluble	NULL
IL-2R	NULL
correlated	NULL
positively	NULL
with	NULL
proliferation	NULL
.	NULL

In	NULL
comparison	NULL
with	NULL
other	NULL
stimuli	NULL
that	NULL
induce	NULL
transient	NULL
expression	NULL
,	NULL
we	NULL
also	NULL
observed	NULL
that	NULL
CD2+CD28	NULL
stimulation	NULL
induced	NULL
high-level	NULL
IL-2	NULL
secretion	NULL
and	NULL
receptivity	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
Activation	NULL
after	NULL
CD24+CD28	NULL
Costimulation	NULL
.	NULL

In	NULL
regard	NULL
to	NULL
the	NULL
putative	NULL
central	NULL
role	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
T-lymphocyte	NULL
activation	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
CD2+CD28	NULL
costimulation	NULL
efficiently	NULL
induced	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
primary	NULL
human	NULL
T-cells	NULL
.	NULL

«	NULL
B-binding	NULL
proteins	NULL
present	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
T-cells	NULL
treated	NULL
by	NULL
different	NULL
stimuli	NULL
were	NULL
first	NULL
detected	NULL
by	NULL
EMSA	NULL
with	NULL
a	NULL
synthetic	NULL
oligonucleotide	NULL
probe	NULL
containing	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
of	NULL
the	NULL
«	NULL
Ig	NULL
light	NULL
chain	NULL
enhancer	NULL
(	NULL
17	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

All	NULL
three	NULL
stimuli	NULL
strongly	NULL
induced	NULL
a	NULL
slow-migrating	NULL
complex	NULL
of	NULL
comparable	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
Lane	NULL
2	NULL
compared	NULL
to	NULL
Lanes	NULL
5	NULL
,	NULL
8	NULL
,	NULL
and	NULL
11	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
untreated	NULL
and	NULL
stimulated	NULL
cell	NULL
nuclear	NULL
extracts	NULL
both	NULL
contained	NULL
an	NULL
intense	NULL
,	NULL
faster-migrating	NULL
protein-DNA	NULL
complex	NULL
.	NULL

To	NULL
demonstrate	NULL
the	NULL
sequence	NULL
specificity	NULL
of	NULL
these	NULL
complexes	NULL
,	NULL
we	NULL
performed	NULL
competition	NULL
assays	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
excess	NULL
unlabeled	NULL
wild-type	NULL
or	NULL
mutant	NULL
«	NULL
B	NULL
DNA	NULL
competitor	NULL
oligonucleotides	NULL
.	NULL

The	NULL
more	NULL
intense	NULL
,	NULL
faster-migrating	NULL
complex	NULL
was	NULL
not	NULL
a	NULL
bona	NULL
fide	NULL
NF-	NULL
«	NULL
B-specific	NULL
complex	NULL
,	NULL
since	NULL
it	NULL
was	NULL
almost	NULL
equally	NULL
competed	NULL
by	NULL
wild-type	NULL
and	NULL
mutant	NULL
competitor	NULL
oligonucleotides	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
wild-type	NULL
competitor	NULL
completely	NULL
abrogated	NULL
the	NULL
inducible	NULL
upper	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
Lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
9	NULL
,	NULL
and	NULL
12	NULL
)	NULL
whereas	NULL
the	NULL
mutant	NULL
«	NULL
Ig	NULL
motif	NULL
was	NULL
ineffective	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
Lanes	NULL
4	NULL
,	NULL
7	NULL
,	NULL
10	NULL
,	NULL
and	NULL
11	NULL
)	NULL
.	NULL

These	NULL
data	NULL
show	NULL
that	NULL
peripheral	NULL
human	NULL
T-cells	NULL
respond	NULL
to	NULL
extracellular	NULL
stimuli	NULL
by	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
as	NULL
previously	NULL
reported	NULL
for	NULL
tumoral	NULL
T-cell	NULL
lines	NULL
(	NULL
18	NULL
)	NULL
and	NULL
for	NULL
primary	NULL
resting	NULL
human	NULL
T-cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
exogenous	NULL
IL-2	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Long-Term	NULL
Expression	NULL
of	NULL
Nuclear	NULL
Induced	NULL
«	NULL
B1-22	NULL
,	NULL
-Pro-tein	NULL
Complexes	NULL
in	NULL
CD24CD28-stimulated	NULL
T-Lymphocytes	NULL
.	NULL

The	NULL
long-lasting	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
CD25/	NULL
IL-2Ra	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
,	NULL
apparently	NULL
sustained	NULL
by	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
its	NULL
encoding	NULL
gene	NULL
(	NULL
11	NULL
)	NULL
,	NULL
prompted	NULL
us	NULL
to	NULL
perform	NULL
a	NULL
kinetic	NULL
study	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
activation	NULL
using	NULL
the	NULL
«	NULL
B	NULL
motif	NULL
from	NULL
the	NULL
IL-2Ra	NULL
promoter	NULL
and	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
T-cells	NULL
harvested	NULL
from	NULL
3	NULL
h	NULL
up	NULL
to	NULL
332	NULL
NF-	NULL
«	NULL
B	NULL
Activation	NULL
in	NULL
CD2+CD28-stimulated	NULL
Primary	NULL
T-Cells	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Effect	NULL
of	NULL
TPA	NULL
,	NULL
CD2+	NULL
CD28	NULL
,	NULL
and	NULL
CD2+CD28+TPA	NULL
on	NULL
the	NULL
nuclear	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
purified	NULL
T-cells	NULL
.	NULL

Purified	NULL
human	NULL
T-lymphocytes	NULL
were	NULL
stimulated	NULL
for	NULL
24	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Competitor	NULL
:	NULL
_o	NULL
_	NULL
Free	NULL
probe	NULL
[	NULL
>	NULL
1	NULL
2	NULL
Uz	NULL
``	NULL
p	NULL
g	NULL
)	NULL
7	NULL
:	NULL
~5g	NULL
p	NULL
$	NULL
$	NULL
CD2	NULL
+	NULL
CD28	NULL
€	NULL
L	NULL
l	NULL
s	NULL
sss	NULL
$	NULL
$	NULL
0	NULL
o	NULL
hes	NULL
$	NULL
-	NULL
«	NULL
<	NULL
©	NULL
Cles	NULL
$	NULL
5	NULL
&	NULL
«	NULL
P	NULL
8	NULL
S	NULL
a	NULL
a	NULL
-	NULL
<	NULL
A	NULL
L	NULL
]	NULL
I	NULL
pH	NULL
E5	NULL
ao	NULL
-	NULL
<	NULL
D	NULL
1	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
9	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Demonstration	NULL
that	NULL
T-cell	NULL
activation	NULL
via	NULL
CD2+CD28	NULL
induced	NULL
long-lasting	NULL
(	NULL
>	NULL
3	NULL
weeks	NULL
)	NULL
nuclear	NULL
expression	NULL
of	NULL
«	NULL
Bi.22	NULL
,	NULL
DNA-binding	NULL
pro-teins	NULL
.	NULL

Highly	NULL
purified	NULL
human	NULL
T-lymphocytes	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
with	NULL
CD2	NULL
and	NULL
CD28	NULL
mAbs	NULL
(	NULL
see	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
)	NULL
.	NULL

After	NULL
increasing	NULL
times	NULL
of	NULL
incubation	NULL
,	NULL
cell	NULL
samples	NULL
were	NULL
harvested	NULL
by	NULL
centrifugation	NULL
at	NULL
4°C	NULL
,	NULL
rapidly	NULL
cooled	NULL
in	NULL
ice	NULL
water	NULL
,	NULL
and	NULL
kept	NULL
frozen	NULL
at	NULL
-80°C	NULL
until	NULL
nuclear	NULL
extract	NULL
preparation	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
simultaneously	NULL
when	NULL
all	NULL
cell	NULL
samples	NULL
were	NULL
harvested	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
proteins	NULL
(	NULL
1	NULL
ug/reaction	NULL
)	NULL
were	NULL
analyzed	NULL
for	NULL
«	NULL
B-specific	NULL
DNA	NULL
binding	NULL
in	NULL
EMSAs	NULL
using	NULL
a	NULL
**P-labeled	NULL
DNA	NULL
probe	NULL
containing	NULL
the	NULL
wild-type	NULL
binding	NULL
site	NULL
for	NULL
NF-	NULL
«	NULL
8	NULL
from	NULL
the	NULL
/L-2Ra	NULL
gene	NULL
promoter	NULL
.	NULL

The	NULL
fluorogram	NULL
of	NULL
a	NULL
native	NULL
gel	NULL
,	NULL
representative	NULL
of	NULL
4	NULL
independent	NULL
experiments	NULL
,	NULL
is	NULL
shown	NULL
.	NULL

Only	NULL
the	NULL
upper	NULL
part	NULL
of	NULL
the	NULL
gel	NULL
containing	NULL
the	NULL
retarded	NULL
complex	NULL
is	NULL
presented	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
unstimulated	NULL
T-lymphocytes	NULL
.	NULL

Lanes	NULL
2-9	NULL
,	NULL
CD2+CD28	NULL
stimulation	NULL
.	NULL

Lane	NULL
2	NULL
,	NULL
3	NULL
h	NULL
;	NULL
Lane	NULL
3	NULL
,	NULL
6	NULL
h	NULL
;	NULL
Lane	NULL
4	NULL
,	NULL
24	NULL
h	NULL
;	NULL
Lane	NULL
5	NULL
,	NULL
48	NULL
h	NULL
;	NULL
Lane	NULL
6	NULL
,	NULL
96	NULL
h	NULL
;	NULL
Lane	NULL
7	NULL
,	NULL
1	NULL
week	NULL
;	NULL
Lane	NULL
8	NULL
,	NULL
2	NULL
weeks	NULL
;	NULL
and	NULL
Lane	NULL
9	NULL
,	NULL
3	NULL
weeks	NULL
.	NULL

Arrowheads	NULL
,	NULL
A	NULL
,	NULL
B	NULL
,	NULL
C	NULL
,	NULL
and	NULL
D	NULL
complexes	NULL
.	NULL

K	NULL
>	NULL
=	NULL
<	NULL
n	NULL
:	NULL
waa	NULL
-	NULL
wal	NULL
_	NULL
4G	NULL
NF-kB	NULL
10	NULL
11	NULL
-	NULL
a	NULL
submitogenic	NULL
concentration	NULL
of	NULL
TPA	NULL
(	NULL
107°	NULL
m	NULL
)	NULL
and	NULL
saturating	NULL
Ry	NULL
amounts	NULL
of	NULL
CD2	NULL
and	NULL
CD28	NULL
mAbs	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
|	NULL
simultaneously	NULL
,	NULL
and	NULL
equal	NULL
amounts	NULL
of	NULL
protein	NULL
were	NULL
analyzed	NULL
for	NULL
«	NULL
B-specific	NULL
DNA	NULL
binding	NULL
in	NULL
EMSAs	NULL
using	NULL
a	NULL
``	NULL
P-labeled	NULL
DNA	NULL
probe	NULL
(	NULL
«	NULL
B.	NULL
,	NULL
synthetic	NULL
oligonucleotide	NULL
)	NULL
.	NULL

A	NULL
representative	NULL
fluorogram	NULL
of	NULL
a	NULL
native	NULL
gel	NULL
is	NULL
shown	NULL
.	NULL

Stimulation	NULL
conditions	NULL
are	NULL
indicated	NULL
above	NULL
the	NULL
fluorogram	NULL
.	NULL

Reaction	NULL
mixtures	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
a	NULL
200-fold	NULL
excess	NULL
unlabeled	NULL
DNA	NULL
competitor	NULL
as	NULL
indicated	NULL
at	NULL
top	NULL
of	NULL
lanes	NULL
.	NULL

Open	NULL
arrowhead	NULL
,	NULL
the	NULL
unbound	NULL
DNA	NULL
probe	NULL
;	NULL
filled	NULL
arrowheads	NULL
,	NULL
the	NULL
inducible	NULL
complex	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
and	NULL
a	NULL
nonspecific	NULL
complex	NULL
(	NULL
ns	NULL
)	NULL
.	NULL

WT	NULL
,	NULL
wild-type	NULL
;	NULL
M	NULL
,	NULL
mutant	NULL
.	NULL

12	NULL
13	NULL
3	NULL
weeks	NULL
after	NULL
CD2+CD28	NULL
costimulation	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
EMSA	NULL
performed	NULL
with	NULL
«	NULL
Buse	NULL
,	NULL
elicited	NULL
a	NULL
more	NULL
complex	NULL
pattern	NULL
of	NULL
retarded	NULL
bands	NULL
than	NULL
with	NULL
the	NULL
DNA	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

This	NULL
pattern	NULL
is	NULL
specific	NULL
to	NULL
the	NULL
«	NULL
Bir	NULL
.	NULL

motif	NULL
,	NULL
as	NULL
it	NULL
was	NULL
also	NULL
observed	NULL
after	NULL
CD3	NULL
and	NULL
TPA	NULL
stimulation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
cells	NULL
contained	NULL
two	NULL
protein-DNA	NULL
complexes	NULL
,	NULL
C	NULL
and	NULL
D.	NULL
The	NULL
intensity	NULL
of	NULL
band	NULL
C	NULL
was	NULL
variable	NULL
depending	NULL
on	NULL
the	NULL
batch	NULL
of	NULL
T-cell	NULL
preparation	NULL
used	NULL
(	NULL
six	NULL
independent	NULL
preparations	NULL
)	NULL
but	NULL
was	NULL
always	NULL
detectable	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
two	NULL
new	NULL
retarded	NULL
bands	NULL
,	NULL
designated	NULL
A	NULL
and	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
Lane	NULL
1	NULL
compared	NULL
to	NULL
Lane	NULL
2	NULL
)	NULL
,	NULL
appeared	NULL
after	NULL
stimulation	NULL
.	NULL

A	NULL
and	NULL
B	NULL
complexes	NULL
were	NULL
present	NULL
in	NULL
nearly	NULL
identical	NULL
amounts	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
T-cells	NULL
harvested	NULL
between	NULL
3	NULL
h	NULL
and	NULL
3	NULL
weeks	NULL
after	NULL
CD2+CD28	NULL
costimulation	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
Lanes	NULL
2-9	NULL
)	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
CD2+CD28	NULL
costimulation	NULL
leads	NULL
to	NULL
the	NULL
persistent	NULL
appearance	NULL
of	NULL
two	NULL
/L-2Ra	NULL
«	NULL
B-binding	NULL
activities	NULL
in	NULL
nuclei	NULL
of	NULL
peripheral	NULL
T-cells	NULL
.	NULL

Characterization	NULL
of	NULL
«	NULL
Bu	NULL
.	NULL

»	NULL
r.-Protein	NULL
Complexes	NULL
.	NULL

We	NULL
performed	NULL
competition	NULL
experiments	NULL
with	NULL
a	NULL
set	NULL
of	NULL
specific	NULL
and	NULL
nonspecific	NULL
unlabeled	NULL
oligonucleotides	NULL
to	NULL
determine	NULL
the	NULL
DNA	NULL
binding	NULL
specificity	NULL
of	NULL
the	NULL
complexes	NULL
binding	NULL
to	NULL
the	NULL
«	NULL
Bir	NULL
.	NULL

probe	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
Lanes	NULL
4-6	NULL
,	NULL
a	NULL
200-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
«	NULL
kB	NULL
sites	NULL
of	NULL
IL-2Ra	NULL
,	NULL
IL-2	NULL
,	NULL
or	NULL
IL-6	NULL
almost	NULL
completely	NULL
abrogated	NULL
the	NULL
three	NULL
upper	NULL
bands	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C.	NULL
In	NULL
contrast	NULL
,	NULL
SP1	NULL
or	NULL
mutant	NULL
«	NULL
lg	NULL
oligonucleotides	NULL
had	NULL
little	NULL
effect	NULL
on	NULL
these	NULL
bands	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
Lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

The	NULL
faster-migrating	NULL
intense	NULL
D	NULL
complex	NULL
was	NULL
apparently	NULL
nonspecific	NULL
.	NULL

To	NULL
characterize	NULL
the	NULL
three	NULL
«	NULL
Bi	NULL
sr.	NULL
,	NULL
-specific	NULL
complexes	NULL
,	NULL
we	NULL
included	NULL
five	NULL
different	NULL
NF-	NULL
«	NULL
B	NULL
antisera	NULL
in	NULL
binding	NULL
reaction	NULL
mixtures	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Rabbit	NULL
antisera	NULL
to	NULL
portions	NULL
of	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
v	NULL
¢	NULL
A	NULL
aA	NULL
A	NULL
A	NULL
OCO	NULL
U	NULL
>	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
1	NULL
2	NULL
3	NULL
4	NULL
recombinant	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
c-Rel	NULL
were	NULL
used	NULL
(	NULL
30	NULL
)	NULL
.	NULL

As	NULL
reported	NULL
by	NULL
Kieran	NULL
et	NULL
al	NULL
.	NULL

(	NULL
46	NULL
)	NULL
,	NULL
anti-p50	NULL
no	NULL
.	NULL

2	NULL
recognizes	NULL
both	NULL
KBF1/p50	NULL
homodimer	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
p50-p65	NULL
complexes	NULL
,	NULL
whereas	NULL
anti-p50	NULL
no	NULL
.	NULL

3	NULL
recognizes	NULL
only	NULL
KBF1/	NULL
p50	NULL
homodimer	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
complexes	NULL
were	NULL
tested	NULL
for	NULL
inhibition	NULL
by	NULL
the	NULL
recombinant	NULL
I	NULL
«	NULL
B	NULL
protein	NULL
MAD-3	NULL
,	NULL
*	NULL
which	NULL
inhibits	NULL
DNA	NULL
binding	NULL
of	NULL
both	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
c-Rel	NULL
(	NULL
25	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
from	NULL
competition	NULL
experiments	NULL
,	NULL
the	NULL
nonspecific	NULL
band	NULL
D	NULL
was	NULL
unaffected	NULL
by	NULL
the	NULL
different	NULL
antisera	NULL
or	NULL
recombinant	NULL
MAD-3	NULL
in	NULL
binding	NULL
reaction	NULL
mixtures	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
Lanes	NULL
2-8	NULL
)	NULL
.	NULL

Constitutively	NULL
expressed	NULL
band	NULL
C	NULL
disappeared	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
serum	NULL
anti-p50	NULL
and	NULL
antisera	NULL
no	NULL
.	NULL

2	NULL
and	NULL
no	NULL
.	NULL

3	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
Lanes	NULL
2	NULL
,	NULL
6	NULL
,	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Anti-p65	NULL
,	NULL
anti-c-Rel	NULL
,	NULL
and	NULL
recombinant	NULL
MAD-3	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
Lanes	NULL
3	NULL
,	NULL
4	NULL
,	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
identified	NULL
band	NULL
C	NULL
as	NULL
the	NULL
*	NULL
U	NULL
,	NULL
Zabel	NULL
,	NULL
T.	NULL
Hankel	NULL
,	NULL
M.	NULL
Dos	NULL
Santos	NULL
Silva	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

Nuclear	NULL
uptake	NULL
control	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
MAD-3	NULL
,	NULL
and	NULL
I	NULL
«	NULL
B	NULL
protein	NULL
present	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
12	NULL
;	NULL
201-211	NULL
,	NULL
1993.	NULL
a	NULL
<	NULL
A	NULL
1	NULL
__	NULL
‘	NULL
<	NULL
B	NULL
<	NULL
C	NULL
u	NULL
“	NULL
40	NULL
6	NULL
8	NULL
A	NULL
_	NULL
B	NULL
kd	NULL
amu	NULL
»	NULL
4	NULL
124	NULL
#	NULL
4	NULL
-	NULL
94	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Characterization	NULL
and	NULL
identification	NULL
of	NULL
kBu.ze	NULL
,	NULL
motif-binding	NULL
proteins	NULL
induced	NULL
by	NULL
CD2+CD28	NULL
.	NULL

A	NULL
,	NULL
«	NULL
8	NULL
specificity	NULL
of	NULL
the	NULL
DNA-protein	NULL
-	NULL
complexes	NULL
.	NULL

Nuclear	NULL
extract	NULL
(	NULL
1	NULL
ag	NULL
)	NULL
from	NULL
purified	NULL
human	NULL
T-lymphocytes	NULL
stimulated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
CD2	NULL
and	NULL
CD28	NULL
mAbs	NULL
was	NULL
incubated	NULL
with	NULL
``	NULL
P-labeled	NULL
oligonucleotide	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
set	NULL
of	NULL
«	NULL
B-specific	NULL
and	NULL
nonspecific	NULL
DNA	NULL
competitors	NULL
{	NULL
(	NULL
200-fold	NULL
excess	NULL
;	NULL
see	NULL
``	NULL
Materials	NULL
and	NULL
Meth-ods	NULL
``	NULL
)	NULL
as	NULL
indicated	NULL
at	NULL
top	NULL
of	NULL
lanes	NULL
(	NULL
Lanes	NULL
2-6	NULL
)	NULL
.	NULL

The	NULL
resultant	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
-	NULL
resolved	NULL
on	NULL
5	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

8	NULL
,	NULL
identification	NULL
of	NULL
NF-	NULL
«	NULL
B-like	NULL
complexes	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
above	NULL
and	NULL
incubated	NULL
with	NULL
``	NULL
P-labeled	NULL
«	NULL
B	NULL
,	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
specific	NULL
NF-	NULL
«	NULL
B	NULL
antisera	NULL
and	NULL
recombinant	NULL
MAD-3/l	NULL
«	NULL
B	NULL
as	NULL
indicated	NULL
at	NULL
top	NULL
of	NULL
lanes	NULL
using	NULL
conditions	NULL
previously	NULL
described	NULL
by	NULL
Kieran	NULL
et	NULL
al	NULL
.	NULL

(	NULL
46	NULL
)	NULL
and	NULL
Tewari	NULL
et	NULL
al	NULL
.	NULL

(	NULL
30	NULL
)	NULL
.	NULL

Open	NULL
circles	NULL
,	NULL
two	NULL
DNA-binding	NULL
activities	NULL
contributed	NULL
by	NULL
rabbit	NULL
antisera	NULL
;	NULL
filled	NULL
arrowheads	NULL
,	NULL
the	NULL
three	NULL
«	NULL
B-specific	NULL
complexes	NULL
(	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
,	NULL
respec-tively	NULL
)	NULL
;	NULL
open	NULL
arrowhead	NULL
,	NULL
nonspecific	NULL
complex	NULL
D.	NULL
C	NULL
,	NULL
UV-cross-linking	NULL
of	NULL
pro-teins	NULL
.	NULL

EMSA	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
a	NULL
5-bromo-2'-deoxyuridine	NULL
5'-triphosphate-substituted	NULL
«	NULL
Bi.sr	NULL
.	NULL

probe	NULL
and	NULL
nuclear	NULL
extracts	NULL
(	NULL
4	NULL
ug	NULL
)	NULL
from	NULL
CD2+CD28-stimulated	NULL
T-cells	NULL
.	NULL

The	NULL
wet	NULL
gels	NULL
were	NULL
irradiated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
312	NULL
nm	NULL
and	NULL
autoradiographed	NULL
,	NULL
and	NULL
gel	NULL
slabs	NULL
corresponding	NULL
to	NULL
the	NULL
two	NULL
main	NULL
inducible	NULL
bands	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
were	NULL
migrated	NULL
on	NULL
denaturing	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Numbers	NULL
at	NULL
right	NULL
,	NULL
molecular	NULL
weight	NULL
determined	NULL
by	NULL
comparison	NULL
to	NULL
molecular	NULL
weight	NULL
markers	NULL
(	NULL
filled	NULL
arrowheads	NULL
,	NULL
main	NULL
polypeptide	NULL
_	NULL
adducts	NULL
)	NULL
.	NULL

-	NULL
Stars	NULL
,	NULL
other	NULL
minor	NULL
bands	NULL
.	NULL

KBF1/p50	NULL
homodimer	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Complex	NULL
B	NULL
formation	NULL
was	NULL
inhibited	NULL
with	NULL
anti-p65	NULL
and	NULL
no	NULL
.	NULL

2	NULL
antisera	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
Lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
as	NULL
well	NULL
as	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
recombinant	NULL
MAD-3	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
Lane	NULL
8	NULL
)	NULL
.	NULL

In	NULL
parallel	NULL
,	NULL
anti-p50	NULL
,	NULL
anti-c-Rel	NULL
,	NULL
and	NULL
no	NULL
.	NULL

3	NULL
antisera	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
Lanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
and	NULL
7	NULL
)	NULL
.	NULL

We	NULL
concluded	NULL
that	NULL
band	NULL
B	NULL
corresponded	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
p50-p65	NULL
heterodimers	NULL
.	NULL

The	NULL
nature	NULL
of	NULL
band	NULL
A	NULL
was	NULL
more	NULL
puz-zling	NULL
.	NULL

None	NULL
of	NULL
the	NULL
five	NULL
antisera	NULL
significantly	NULL
affected	NULL
the	NULL
formation	NULL
of	NULL
this	NULL
inducible	NULL
«	NULL
Buse	NULL
.	NULL

complex	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
Lanes	NULL
2-4	NULL
,	NULL
6	NULL
,	NULL
and	NULL
7	NULL
)	NULL
.	NULL

However	NULL
,	NULL
incubation	NULL
with	NULL
recombinant	NULL
MAD-3	NULL
completely	NULL
inhibited	NULL
band	NULL
A	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
Lane	NULL
8	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
inducible	NULL
complex	NULL
A	NULL
contained	NULL
at	NULL
least	NULL
one	NULL
NF-	NULL
«	NULL
B/c-Rel-like	NULL
subunit	NULL
able	NULL
to	NULL
interact	NULL
with	NULL
MAD-3	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
reactivity	NULL
with	NULL
anti-p65	NULL
or	NULL
anti-c-Rel	NULL
does	NULL
not	NULL
necessarily	NULL
exclude	NULL
the	NULL
presence	NULL
of	NULL
p65	NULL
or	NULL
c-Rel	NULL
subunits	NULL
in	NULL
complex	NULL
A	NULL
,	NULL
since	NULL
epitopes	NULL
could	NULL
be	NULL
masked	NULL
upon	NULL
dimer	NULL
formation	NULL
or	NULL
upon	NULL
binding	NULL
to	NULL
DNA	NULL
.	NULL

UV-cross-linking	NULL
experiments	NULL
were	NULL
performed	NULL
to	NULL
further	NULL
characterize	NULL
the	NULL
inducible	NULL
bands	NULL
A	NULL
and	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

Complex	NULL
A	NULL
revealed	NULL
only	NULL
one	NULL
polypeptide	NULL
at	NULL
94	NULL
kDa	NULL
,	NULL
a	NULL
333	NULL
334	NULL
-	NULL
NF-	NULL
«	NULL
B	NULL
Activation	NULL
in	NULL
CO2+CD28-stimulated	NULL
Primary	NULL
T-Cells	NULL
size	NULL
relatively	NULL
close	NULL
to	NULL
85	NULL
kDa	NULL
,	NULL
the	NULL
reported	NULL
size	NULL
of	NULL
c-Rel	NULL
protein	NULL
adduct	NULL
(	NULL
47	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
Lane	NULL
1	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
complex	NULL
A	NULL
could	NULL
correspond	NULL
to	NULL
R	NULL
«	NULL
B	NULL
,	NULL
a	NULL
107	NULL
kDa	NULL
product	NULL
encoded	NULL
by	NULL
a	NULL
gene	NULL
recently	NULL
cloned	NULL
(	NULL
48	NULL
)	NULL
.	NULL

R	NULL
«	NULL
B	NULL
was	NULL
originally	NULL
characterized	NULL
as	NULL
a	NULL
«	NULL
Biu.r	NULL
,	NULL
DNA-binding	NULL
complex	NULL
present	NULL
in	NULL
PMA-induced	NULL
Jurkat	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

However	NULL
,	NULL
this	NULL
protein	NULL
is	NULL
related	NULL
to	NULL
the	NULL
regulatory	NULL
protein	NULL
MyoD	NULL
but	NULL
not	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
gene	NULL
family	NULL
,	NULL
since	NULL
it	NULL
lacks	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
.	NULL

Despite	NULL
the	NULL
lack	NULL
of	NULL
effect	NULL
of	NULL
antisera	NULL
,	NULL
we	NULL
tentatively	NULL
identified	NULL
complex	NULL
A	NULL
as	NULL
a	NULL
c-Rel-like	NULL
protein	NULL
homodimer	NULL
or	NULL
a	NULL
c-Rel-p65	NULL
complex	NULL
in	NULL
accordance	NULL
with	NULL
recombinant	NULL
MAD-3	NULL
inhibition	NULL
.	NULL

As	NULL
expected	NULL
from	NULL
antisera	NULL
characterization	NULL
,	NULL
band	NULL
B	NULL
elicited	NULL
a	NULL
pattern	NULL
of	NULL
radiolabeled	NULL
proteins	NULL
very	NULL
similar	NULL
to	NULL
the	NULL
composition	NULL
of	NULL
the	NULL
late-phase	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
present	NULL
in	NULL
PMA-induced	NULL
Jurkat	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
(	NULL
22	NULL
)	NULL
.	NULL

As	NULL
reported	NULL
by	NULL
Molitor	NULL
et	NULL
al	NULL
.	NULL

(	NULL
22	NULL
)	NULL
,	NULL
the	NULL
major	NULL
57	NULL
kDa	NULL
polypeptide	NULL
most	NULL
probably	NULL
corresponds	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
,	NULL
and	NULL
the	NULL
124	NULL
kDa	NULL
adduct	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
both	NULL
cross-linked	NULL
to	NULL
the	NULL
same	NULL
probe	NULL
.	NULL

Finally	NULL
,	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
apparent	NULL
constant	NULL
pattern	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
revealed	NULL
by	NULL
EMSA	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
similar	NULL
results	NULL
were	NULL
obtained	NULL
when	NULL
experiments	NULL
were	NULL
performed	NULL
using	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
at	NULL
3	NULL
h	NULL
,	NULL
24	NULL
h	NULL
,	NULL
and	NULL
3	NULL
weeks	NULL
after	NULL
CD2+CD28	NULL
costimulation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

CD24+CD28	NULL
Activation	NULL
of	NULL
T-Cells	NULL
Depleted	NULL
Intracellular	NULL
Thiols	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
u-cysteine	NULL
and	NULL
N-acetyl-L-cysteine	NULL
effects	NULL
,	NULL
intracellular	NULL
thiol	NULL
levels	NULL
appear	NULL
to	NULL
play	NULL
a	NULL
key	NULL
role	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
Jurkat	NULL
T-cells	NULL
stimulated	NULL
by	NULL
PMA	NULL
and	NULL
TNF-a	NULL
(	NULL
35	NULL
,	NULL
38	NULL
)	NULL
.	NULL

To	NULL
evaluate	NULL
thiol	NULL
involvement	NULL
in	NULL
T-cell	NULL
activation	NULL
by	NULL
CD24+CD28	NULL
,	NULL
we	NULL
measured	NULL
by	NULL
flow	NULL
cytometry	NULL
the	NULL
levels	NULL
of	NULL
glutathione	NULL
,	NULL
the	NULL
major	NULL
intracellular	NULL
ROI	NULL
scavenger	NULL
(	NULL
38	NULL
,	NULL
49	NULL
,	NULL
50	NULL
)	NULL
.	NULL

We	NULL
used	NULL
an	NULL
assay	NULL
based	NULL
on	NULL
monochlorobimane	NULL
,	NULL
a	NULL
membrane-per-meant	NULL
nonfluorescent	NULL
substrate	NULL
that	NULL
becomes	NULL
fluorescent	NULL
after	NULL
reaction	NULL
with	NULL
a	NULL
sulfhydryl	NULL
group	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Within	NULL
cells	NULL
,	NULL
it	NULL
is	NULL
almost	NULL
exclusively	NULL
coupled	NULL
to	NULL
glutathione	NULL
by	NULL
glutathione-S-transferase	NULL
(	NULL
49	NULL
)	NULL
.	NULL

In	NULL
accordance	NULL
with	NULL
a	NULL
role	NULL
of	NULL
oxidative	NULL
stress	NULL
in	NULL
transduction	NULL
of	NULL
CD2+CD28-triggered	NULL
signals	NULL
,	NULL
we	NULL
observed	NULL
a	NULL
rapid	NULL
decrease	NULL
in	NULL
total	NULL
thiol	NULL
content	NULL
following	NULL
T-cell	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

A	NULL
comparative	NULL
flow	NULL
cytometry	NULL
distribution	NULL
of	NULL
control	NULL
unstimulated	NULL
cells	NULL
(	NULL
a	NULL
,	NULL
mean	NULL
fluorescence	NULL
98	NULL
)	NULL
and	NULL
CD2+CD28-triggered	NULL
cells	NULL
15	NULL
min	NULL
after	NULL
stimulation	NULL
(	NULL
b	NULL
,	NULL
mean	NULL
fluorescence	NULL
75	NULL
)	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
.	NULL

This	NULL
representative	NULL
experiment	NULL
,	NULL
of	NULL
four	NULL
experiments	NULL
performed	NULL
,	NULL
demonstrated	NULL
a	NULL
significant	NULL
decrease	NULL
(	NULL
23.5	NULL
%	NULL
)	NULL
of	NULL
relative	NULL
thiol	NULL
levels	NULL
.	NULL

Flow	NULL
cytometry	NULL
distribution	NULL
evidenced	NULL
a	NULL
heterogeneity	NULL
in	NULL
the	NULL
populational	NULL
thiol	NULL
content	NULL
of	NULL
stimulated	NULL
cells	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
resting	NULL
lymphocytes	NULL
.	NULL

Heterogeneity	NULL
of	NULL
thiol	NULL
levels	NULL
could	NULL
be	NULL
interpreted	NULL
as	NULL
the	NULL
consequence	NULL
of	NULL
differential	NULL
CD2	NULL
and	NULL
CD28	NULL
T-cell	NULL
surface	NULL
expression	NULL
.	NULL

Although	NULL
CD2	NULL
is	NULL
expressed	NULL
in	NULL
nearly	NULL
all	NULL
cells	NULL
,	NULL
only	NULL
50	NULL
%	NULL
of	NULL
CD8+	NULL
T-lymphocytes	NULL
express	NULL
CD28	NULL
(	NULL
2	NULL
)	NULL
.	NULL

During	NULL
the	NULL
early	NULL
phase	NULL
of	NULL
CD2+CD28	NULL
stimulation	NULL
,	NULL
half	NULL
of	NULL
the	NULL
CD8+	NULL
cells	NULL
(	NULL
ap-proximately	NULL
20	NULL
%	NULL
of	NULL
the	NULL
whole	NULL
population	NULL
)	NULL
are	NULL
not	NULL
directly	NULL
triggered	NULL
,	NULL
and	NULL
therefore	NULL
,	NULL
their	NULL
intracellular	NULL
thiol	NULL
level	NULL
remains	NULL
at	NULL
the	NULL
basal	NULL
level	NULL
until	NULL
a	NULL
second	NULL
signal	NULL
is	NULL
provided	NULL
(	NULL
such	NULL
as	NULL
IL-2	NULL
secretion	NULL
by	NULL
CD4+	NULL
cells	NULL
)	NULL
.	NULL

in	NULL
an	NULL
attempt	NULL
to	NULL
correlate	NULL
thiol	NULL
level	NULL
variation	NULL
and	NULL
long-term	NULL
activation	NULL
,	NULL
we	NULL
performed	NULL
a	NULL
kinetic	NULL
study	NULL
of	NULL
intracellular	NULL
thiol	NULL
levels	NULL
during	NULL
T-lymphocyte	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
T-cells	NULL
via	NULL
CD2+CD28	NULL
resulted	NULL
in	NULL
an	NULL
immediate	NULL
decrease	NULL
in	NULL
intracellular	NULL
thiol	NULL
levels	NULL
,	NULL
with	NULL
a	NULL
maximum	NULL
decrease	NULL
{	NULL
36	NULL
%	NULL
)	NULL
at	NULL
30	NULL
min	NULL
.	NULL

The	NULL
stimulated	NULL
cells	NULL
55	NULL
a	NULL
r	NULL
b	NULL
Lo	NULL
-	NULL
33	NULL
©	NULL
A	NULL
5	NULL
3	NULL
-	NULL
22	NULL
$	NULL
0	NULL
1	NULL
0	NULL
A.	NULL
o	NULL
so	NULL
-	NULL
100	NULL
150	NULL
200	NULL
-	NULL
250	NULL
FLUORESCENCE	NULL
INTENSITY	NULL
B	NULL
(	NULL
1	NULL
110	NULL
-	NULL
I	NULL
T	NULL
100	NULL
-	NULL
J/O\	NULL
(	NULL
T	NULL
)	NULL
<	NULL
I	NULL
4	NULL
e	NULL
a	NULL
'	NULL
®	NULL
90	NULL
-	NULL
J	NULL
3	NULL
|	NULL
*	NULL
3	NULL
T	NULL
&	NULL
80	NULL
-	NULL
/	NULL
3	NULL
(	NULL
[	NULL
0-0	NULL
o	NULL
70	NULL
-	NULL
o—O/	NULL
of	NULL
/	NULL
so	NULL
-	NULL
J.	NULL
J	NULL
so	NULL
-	NULL
-	NULL
10	NULL
o	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
20	NULL
30	NULL
40	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Thiol	NULL
and	NULL
glutathione	NULL
level	NULL
during	NULL
CD2+CD28	NULL
T-cell	NULL
activation	NULL
.	NULL

Cells	NULL
were	NULL
stained	NULL
with	NULL
MCB	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

A	NULL
,	NULL
the	NULL
comparative	NULL
flow	NULL
cytometry	NULL
distribution	NULL
of	NULL
purified	NULL
T-cells	NULL
either	NULL
unstimulated	NULL
(	NULL
a	NULL
,	NULL
gray	NULL
area	NULL
)	NULL
or	NULL
15	NULL
min	NULL
after	NULL
CD2+CD28	NULL
stimulation	NULL
(	NULL
b	NULL
,	NULL
white	NULL
area	NULL
)	NULL
.	NULL

Note	NULL
the	NULL
lack	NULL
of	NULL
heterogeneity	NULL
in	NULL
populational	NULL
thiol	NULL
content	NULL
for	NULL
unstimulated	NULL
cells	NULL
(	NULL
a	NULL
)	NULL
in	NULL
contrast	NULL
to	NULL
stimulated	NULL
cells	NULL
(	NULL
b	NULL
)	NULL
.	NULL

This	NULL
is	NULL
a	NULL
representative	NULL
experiment	NULL
of	NULL
4	NULL
performed	NULL
.	NULL

B	NULL
,	NULL
the	NULL
time	NULL
course	NULL
of	NULL
internal	NULL
thiol	NULL
concentration	NULL
after	NULL
CD2+CD28	NULL
stimulation	NULL
.	NULL

Relative	NULL
thiol	NULL
levels	NULL
were	NULL
determined	NULL
from	NULL
the	NULL
scaled	NULL
mean	NULL
of	NULL
MCB	NULL
fluorescence	NULL
.	NULL

The	NULL
internal	NULL
thiol	NULL
level	NULL
without	NULL
stimulation	NULL
is	NULL
given	NULL
as	NULL
100	NULL
%	NULL
.	NULL

Thiol	NULL
levels	NULL
in	NULL
unstimulated	NULL
cells	NULL
cultured	NULL
for	NULL
the	NULL
same	NULL
length	NULL
of	NULL
time	NULL
did	NULL
not	NULL
rise	NULL
or	NULL
fall	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
variations	NULL
observed	NULL
were	NULL
due	NULL
to	NULL
CD2+CD28	NULL
stimulation	NULL
.	NULL

Approximately	NULL
10°	NULL
cells/well	NULL
(	NULL
1	NULL
ml	NULL
total	NULL
volume	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
24-well	NULL
plates	NULL
(	NULL
Costar	NULL
,	NULL
Falcon	NULL
}	NULL
for	NULL
15	NULL
min	NULL
to	NULL
36	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

Each	NULL
point	NULL
is	NULL
the	NULL
average	NULL
of	NULL
4	NULL
independent	NULL
measurements	NULL
.	NULL

Bars	NULL
,	NULL
SD	NULL
.	NULL

To	NULL
emphasize	NULL
the	NULL
early	NULL
phase	NULL
after	NULL
stimulation	NULL
,	NULL
a	NULL
break	NULL
was	NULL
introduced	NULL
in	NULL
horizontal	NULL
scale	NULL
between	NULL
8	NULL
and	NULL
12	NULL
h.	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
335	NULL
CD2	NULL
+	NULL
CD28	NULL
[	NULL
I	NULL
Bs	NULL
P	NULL
3	NULL
3	NULL
2	NULL
§	NULL
<	NULL
&	NULL
$	NULL
&	NULL
&	NULL
a	NULL
ks	NULL
E	NULL
CS	NULL
6	NULL
o	NULL
o	NULL
3	NULL
5	NULL
oa	NULL
§	NULL
5	NULL
&	NULL
&	NULL
&	NULL
§s	NULL
Q	NULL
40	NULL
2	NULL
@	NULL
o	NULL
#	NULL
(	NULL
NF	NULL
-	NULL
kB	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Effects	NULL
of	NULL
thiol	NULL
compounds	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
via	NULL
CD2+CD28	NULL
T-cell	NULL
stimulation	NULL
.	NULL

Purified	NULL
T-cells	NULL
were	NULL
stimulated	NULL
with	NULL
CD2	NULL
and	NULL
CD28	NULL
mAbs	NULL
for	NULL
24	NULL
h	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
Lanes	NULL
1-3	NULL
)	NULL
and	NULL
presence	NULL
(	NULL
Lanes	NULL
4-7	NULL
)	NULL
of	NULL
the	NULL
indicated	NULL
compounds	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
analyzed	NULL
for	NULL
xB-specific	NULL
DNA	NULL
binding	NULL
in	NULL
EMSA	NULL
using	NULL
a	NULL
«	NULL
ig	NULL
motif	NULL
.	NULL

As	NULL
indicated	NULL
at	NULL
top	NULL
of	NULL
the	NULL
lanes	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
PDTC	NULL
on	NULL
nuclear	NULL
CD2+CD28-induced	NULL
NF-	NULL
«	NULL
B	NULL
were	NULL
tested	NULL
at	NULL
concentrations	NULL
between	NULL
1	NULL
am	NULL
and	NULL
0.01	NULL
um	NULL
.	NULL

Pyrrolidine	NULL
,	NULL
a	NULL
cyclic	NULL
molecule	NULL
structurally	NULL
related	NULL
to	NULL
PDTC	NULL
but	NULL
lacking	NULL
a	NULL
dithiocarboxy	NULL
group	NULL
,	NULL
was	NULL
used	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
at	NULL
1	NULL
mm	NULL
.	NULL

Wild-type	NULL
(	NULL
WT	NULL
)	NULL
«	NULL
B	NULL
,	NULL
,	NULL
,	NULL
oligonucleotide	NULL
was	NULL
used	NULL
as	NULL
a	NULL
«	NULL
B-specific	NULL
DNA	NULL
competitor	NULL
(	NULL
see	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
)	NULL
.	NULL

Arrowhead	NULL
,	NULL
the	NULL
NF-	NULL
«	NULL
B-specific	NULL
complex	NULL
;	NULL
stars	NULL
,	NULL
2	NULL
nonspecific	NULL
complexes	NULL
.	NULL

progressively	NULL
regained	NULL
their	NULL
normal	NULL
intracellular	NULL
thiol	NULL
levels	NULL
only	NULL
after	NULL
20	NULL
h.	NULL
Thus	NULL
,	NULL
CD2	NULL
and	NULL
CD28	NULL
costimulation	NULL
induces	NULL
rapid	NULL
production	NULL
of	NULL
reactive	NULL
oxidants	NULL
which	NULL
deplete	NULL
thiol	NULL
levels	NULL
transiently	NULL
,	NULL
in	NULL
positive	NULL
correlation	NULL
with	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
appearance	NULL
.	NULL

PDTC	NULL
Inhibits	NULL
the	NULL
Nuclear	NULL
Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
CD24+CD28	NULL
.	NULL

Previous	NULL
results	NULL
have	NULL
shown	NULL
that	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
intact	NULL
cells	NULL
can	NULL
be	NULL
blocked	NULL
by	NULL
radical-scavenging	NULL
compounds	NULL
(	NULL
36	NULL
,	NULL
37	NULL
,	NULL
51	NULL
)	NULL
.	NULL

Among	NULL
several	NULL
dithio-carbamate	NULL
derivatives	NULL
tested	NULL
,	NULL
PDTC	NULL
,	NULL
as	NULL
a	NULL
potent	NULL
NF-	NULL
«	NULL
B	NULL
inhibitor	NULL
,	NULL
was	NULL
best	NULL
suited	NULL
for	NULL
tumor	NULL
cell	NULL
culture	NULL
experiments	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Consequently	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
in	NULL
vivo	NULL
effects	NULL
of	NULL
PDTC	NULL
on	NULL
purified	NULL
T-lymphocytes	NULL
.	NULL

Phenotypic	NULL
and	NULL
biochemical	NULL
analyses	NULL
were	NULL
performed	NULL
in	NULL
parallel	NULL
using	NULL
the	NULL
same	NULL
cell	NULL
cultures	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
increasing	NULL
amounts	NULL
of	NULL
PDTC	NULL
.	NULL

Gel	NULL
retardation	NULL
analyses	NULL
confirmed	NULL
that	NULL
PDTC	NULL
efficiently	NULL
inhibited	NULL
the	NULL
CD2+CD28-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
purified	NULL
T-lymphocytes	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
detected	NULL
by	NULL
the	NULL
«	NULL
B.	NULL
,	NULL
,	NULL
probe	NULL
were	NULL
fully	NULL
inhibited	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
um	NULL
PDTC	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
Lane	NULL
4	NULL
compared	NULL
to	NULL
Lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

In	NULL
sharp	NULL
contrast	NULL
,	NULL
1	NULL
mm	NULL
pyrrolidine	NULL
,	NULL
the	NULL
end	NULL
product	NULL
of	NULL
PDTC	NULL
oxidation	NULL
but	NULL
lacking	NULL
a	NULL
dithiocarboxy	NULL
group	NULL
,	NULL
had	NULL
no	NULL
detectable	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
Lane	NULL
7	NULL
)	NULL
.	NULL

Comparable	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
the	NULL
«	NULL
Bu	NULL
>	NULL
r	NULL
.	NULL

motif	NULL
,	NULL
as	NULL
inducible	NULL
complexes	NULL
A	NULL
and	NULL
B	NULL
were	NULL
inhibited	NULL
but	NULL
not	NULL
constitutive	NULL
complex	NULL
C	NULL
and	NULL
nonspecific	NULL
complex	NULL
D	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
Radical	NULL
Scavenger	NULL
PDTC	NULL
Inhibits	NULL
T-Cell	NULL
Proliferation	NULL
,	NULL
Cytokine	NULL
Synthesis	NULL
,	NULL
and	NULL
Receptivity	NULL
Induced	NULL
via	NULL
CD24+CD28	NULL
Stimulation	NULL
.	NULL

In	NULL
order	NULL
to	NULL
evaluate	NULL
the	NULL
involve	NULL
T-LYMPHOCYTE	NULL
PROLIFERATION	NULL
IL-2	NULL
SECRETION	NULL
PYRRO	NULL
A	NULL
PYBRO	NULL
Ll	NULL
MEDIUM	NULL
PDTC	NULL
0,01	NULL
PDTC	NULL
0.01	NULL
0.1	NULL
0	NULL
.	NULL

1	NULL
10	NULL
Chi	NULL
pq'1OE	NULL
(	NULL
6	NULL
)	NULL
seeded	NULL
.	NULL

cells	NULL
CD25	NULL
EXPRESSION	NULL
am-csF	NULL
secretion	NULL
D	NULL
C	NULL
evaro	NULL
uou	NULL
.	NULL

|	NULL
;	NULL
°o	NULL
PDTC	NULL
0.01	NULL
-	NULL
|	NULL
|0|	NULL
%	NULL
POSITIVE	NULL
CELLS	NULL
PYaRO	NULL
MEDIUM	NULL
PDTC	NULL
0.01	NULL
6.	NULL
pq/106	NULL
(	NULL
6	NULL
)	NULL
seeded	NULL
.	NULL

cells	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

-	NULL
Effects	NULL
of	NULL
thiol	NULL
compounds	NULL
on	NULL
CD2+CD28-induced	NULL
T-cell	NULL
proliferation	NULL
,	NULL
cytokine	NULL
synthesis	NULL
,	NULL
and	NULL
receptivity	NULL
.	NULL

Purified	NULL
T-lymphocytes	NULL
were	NULL
stimulated	NULL
via	NULL
CD2+CD28	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
PDTC	NULL
(	NULL
ex-pressed	NULL
in	NULL
um	NULL
)	NULL
used	NULL
at	NULL
different	NULL
concentrations	NULL
between	NULL
10	NULL
um	NULL
and	NULL
0.01	NULL
um	NULL
as	NULL
indicated	NULL
at	NULL
bottom	NULL
of	NULL
bars	NULL
.	NULL

Thiol	NULL
compounds	NULL
and	NULL
specific	NULL
mAbs	NULL
were	NULL
added	NULL
simultaneously	NULL
in	NULL
cell	NULL
culture	NULL
.	NULL

As	NULL
controls	NULL
,	NULL
CD2+CD28-stimulated	NULL
T-cell	NULL
cultures	NULL
without	NULL
any	NULL
thiol	NULL
compound	NULL
or	NULL
with	NULL
pyrrolidine	NULL
(	NULL
pyrro	NULL
;	NULL
used	NULL
at	NULL
a	NULL
1	NULL
mm	NULL
concentration	NULL
)	NULL
were	NULL
performed	NULL
.	NULL

Cell	NULL
viability	NULL
was	NULL
controlled	NULL
microscopically	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
and	NULL
in	NULL
no	NULL
case	NULL
was	NULL
less	NULL
than	NULL
90	NULL
%	NULL
.	NULL

Thiol	NULL
compound	NULL
effects	NULL
on	NULL
T-lymphocyte	NULL
proliferation	NULL
(	NULL
A	NULL
)	NULL
were	NULL
measured	NULL
at	NULL
24	NULL
h	NULL
by	NULL
[	NULL
°H	NULL
]	NULL
thymidine	NULL
incorporation	NULL
.	NULL

After	NULL
the	NULL
third	NULL
day	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
}	NULL
,	NULL
proliferation	NULL
was	NULL
restored	NULL
to	NULL
the	NULL
same	NULL
level	NULL
as	NULL
controls	NULL
,	NULL
showing	NULL
the	NULL
absence	NULL
of	NULL
significant	NULL
toxicity	NULL
and	NULL
demonstrating	NULL
the	NULL
reversibility	NULL
of	NULL
PDTC	NULL
effects	NULL
on	NULL
T-cell	NULL
proliferation	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
PDTC	NULL
on	NULL
IL-2	NULL
(	NULL
8	NULL
)	NULL
and	NULL
GM-CSF	NULL
(	NULL
D	NULL
)	NULL
secretion	NULL
were	NULL
measured	NULL
at	NULL
peak	NULL
secretion	NULL
(	NULL
24	NULL
h	NULL
and	NULL
96	NULL
h	NULL
,	NULL
respectively	NULL
)	NULL
with	NULL
an	NULL
ELISA	NULL
assay	NULL
.	NULL

Thiol	NULL
compounds	NULL
did	NULL
not	NULL
interfere	NULL
with	NULL
the	NULL
titration	NULL
method	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
}	NULL
.	NULL

CD25/IL-2Ra	NULL
cell	NULL
surface	NULL
expression	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PDTC	NULL
was	NULL
determined	NULL
at	NULL
36	NULL
h	NULL
by	NULL
flow	NULL
cytometry	NULL
(	NULL
C	NULL
)	NULL
.	NULL

PDTC	NULL
did	NULL
not	NULL
interfere	NULL
with	NULL
flow	NULL
cytometry	NULL
analysis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

ment	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
T-cell	NULL
activation	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
proliferation	NULL
rate	NULL
,	NULL
cytokine	NULL
synthesis	NULL
,	NULL
and	NULL
IL-2	NULL
receptivity	NULL
in	NULL
the	NULL
same	NULL
cell	NULL
cultures	NULL
used	NULL
for	NULL
EMSA	NULL
analysis	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

T-cell	NULL
proliferation	NULL
was	NULL
evaluated	NULL
by	NULL
[	NULL
'	NULL
H	NULL
Ithymidine	NULL
incorporation	NULL
24	NULL
h	NULL
after	NULL
stimulation	NULL
via	NULL
CD2+CD28	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
drug	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

PDTC	NULL
at	NULL
concentrations	NULL
between	NULL
10	NULL
and	NULL
1	NULL
um	NULL
completely	NULL
abrogated	NULL
T-cell	NULL
proliferation	NULL
but	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
thymidine	NULL
incorporation	NULL
below	NULL
0.1	NULL
um	NULL
PDTC	NULL
,	NULL
as	NULL
compared	NULL
to	NULL
no	NULL
addition	NULL
or	NULL
1	NULL
mm	NULL
pyrrolidine	NULL
.	NULL

Cell	NULL
viability	NULL
remained	NULL
better	NULL
than	NULL
90	NULL
%	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
a	NULL
result	NULL
demonstrating	NULL
that	NULL
PDTC	NULL
was	NULL
nontoxic	NULL
for	NULL
purified	NULL
T-lymphocytes	NULL
under	NULL
our	NULL
experimental	NULL
conditions	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
PDTC	NULL
was	NULL
reversible	NULL
,	NULL
as	NULL
[	NULL
H	NULL
]	NULL
thymidine	NULL
incorporation	NULL
in	NULL
PDTC-treated	NULL
cells	NULL
was	NULL
restored	NULL
to	NULL
control	NULL
levels	NULL
after	NULL
48	NULL
h	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IL-2	NULL
secretion	NULL
was	NULL
less	NULL
sensitive	NULL
to	NULL
PDTC	NULL
concentrations	NULL
ranging	NULL
from	NULL
0.1	NULL
to	NULL
1	NULL
um	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
secretion	NULL
was	NULL
completely	NULL
abrogated	NULL
at	NULL
10	NULL
um	NULL
.	NULL

Similarly	NULL
,	NULL
IL-2	NULL
receptivity	NULL
,	NULL
estimated	NULL
by	NULL
CD25/IL-2Ra	NULL
cell	NULL
surface	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
,	NULL
was	NULL
abolished	NULL
only	NULL
when	NULL
the	NULL
PDTC	NULL
concentration	NULL
reached	NULL
10	NULL
um	NULL
.	NULL

GM-CSF	NULL
,	NULL
another	NULL
T-cell-secreted	NULL
cytokine	NULL
not	NULL
directly	NULL
involved	NULL
in	NULL
CD2+CD28	NULL
T-cell	NULL
activation	NULL
,	NULL
but	NULL
whose	NULL
promoter	NULL
contains	NULL
a	NULL
functional	NULL
«	NULL
B	NULL
motif	NULL
(	NULL
18	NULL
)	NULL
,	NULL
showed	NULL
a	NULL
sensitivity	NULL
to	NULL
PDTC	NULL
comparable	NULL
to	NULL
that	NULL
of	NULL
IL-2	NULL
secretion	NULL
(	NULL
Fig	NULL
.	NULL

7D	NULL
)	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
primary	NULL
T-cells	NULL
can	NULL
be	NULL
kept	NULL
alive	NULL
without	NULL
withdrawal	NULL
of	NULL
the	NULL
drug	NULL
for	NULL
at	NULL
least	NULL
4	NULL
days	NULL
at	NULL
PDTC	NULL
concentrations	NULL
that	NULL
are	NULL
optimal	NULL
for	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
cytokine	NULL
secretion	NULL
and	NULL
receptivity	NULL
.	NULL

Further	NULL
336	NULL
-	NULL
NF-	NULL
«	NULL
B	NULL
Activation	NULL
in	NULL
CD2+CD28-stimulated	NULL
Primary	NULL
T-Cells	NULL
more	NULL
,	NULL
they	NULL
confirm	NULL
the	NULL
positive	NULL
correlation	NULL
between	NULL
NF-	NULL
«	NULL
B	NULL
-	NULL
activation	NULL
-	NULL
and	NULL
CD2+CD28-induced	NULL
-	NULL
T-cell	NULL
proliferation	NULL
.	NULL

Discussion	NULL
The	NULL
large	NULL
majority	NULL
of	NULL
studies	NULL
on	NULL
the	NULL
role	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
T-cell	NULL
activation	NULL
were	NULL
performed	NULL
with	NULL
tumor	NULL
cell	NULL
lines	NULL
which	NULL
exhibit	NULL
biological	NULL
characteristics	NULL
that	NULL
are	NULL
not	NULL
manifested	NULL
by	NULL
primary	NULL
T-lymphocytes	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

16	NULL
)	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
only	NULL
one	NULL
recent	NULL
report	NULL
has	NULL
emphasized	NULL
these	NULL
differences	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
function	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
40	NULL
)	NULL
.	NULL

To	NULL
further	NULL
investigate	NULL
the	NULL
role	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
normal	NULL
human	NULL
T-cells	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
nuclear	NULL
appearance	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
highly	NULL
purified	NULL
T-cells	NULL
activated	NULL
by	NULL
monoclonal	NULL
antibodies	NULL
directed	NULL
against	NULL
CD2	NULL
and	NULL
CD28	NULL
adhesion	NULL
molecules	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
here	NULL
support	NULL
the	NULL
hypothesis	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
activation	NULL
and	NULL
long-term	NULL
maintenance	NULL
of	NULL
proliferation	NULL
of	NULL
human	NULL
primary	NULL
T-lymphocytes	NULL
stimulated	NULL
via	NULL
CD2	NULL
and	NULL
CD28	NULL
.	NULL

How	NULL
Is	NULL
the	NULL
Long-Term	NULL
Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
Achieved	NULL
?	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
results	NULL
described	NULL
for	NULL
the	NULL
Jurkat	NULL
T-cell	NULL
line	NULL
treated	NULL
by	NULL
PMA	NULL
,	NULL
we	NULL
have	NULL
observed	NULL
,	NULL
using	NULL
EMSA	NULL
with	NULL
a	NULL
«	NULL
Bu	NULL
.	NULL

»	NULL
r	NULL
,	NULL
probe	NULL
:	NULL
(	NULL
a	NULL
)	NULL
constitutive	NULL
expression	NULL
of	NULL
a	NULL
homodi-meric	NULL
complex	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
subunit	NULL
,	NULL
(	NULL
b	NULL
)	NULL
the	NULL
appearance	NULL
of	NULL
two	NULL
new	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
3	NULL
h	NULL
after	NULL
stimulation	NULL
,	NULL
and	NULL
(	NULL
c	NULL
)	NULL
a	NULL
long-lasting	NULL
maintenance	NULL
(	NULL
3	NULL
weeks	NULL
)	NULL
of	NULL
their	NULL
relative	NULL
levels	NULL
.	NULL

In	NULL
parallel	NULL
,	NULL
we	NULL
observed	NULL
a	NULL
rapid	NULL
and	NULL
transient	NULL
(	NULL
<	NULL
20	NULL
h	NULL
)	NULL
decrease	NULL
in	NULL
thiol	NULL
level	NULL
after	NULL
CD2+CD28	NULL
stimulation	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
nontoxic	NULL
amounts	NULL
of	NULL
PDTC	NULL
fully	NULL
abrogated	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
inhibited	NULL
proliferation	NULL
of	NULL
CD2+CD28-stimulated	NULL
purified	NULL
T-cells	NULL
.	NULL

The	NULL
variation	NULL
of	NULL
thiol	NULL
level	NULL
and	NULL
the	NULL
effects	NULL
of	NULL
PDTC	NULL
evidenced	NULL
a	NULL
role	NULL
for	NULL
oxidoreduction	NULL
mechanisms	NULL
in	NULL
T-cell	NULL
activation	NULL
through	NULL
the	NULL
adhesion	NULL
molecules	NULL
.	NULL

However	NULL
,	NULL
as	NULL
could	NULL
be	NULL
predicted	NULL
in	NULL
view	NULL
of	NULL
the	NULL
inhibiting	NULL
effects	NULL
of	NULL
prolonged	NULL
thiol	NULL
depletion	NULL
in	NULL
human	NULL
purified	NULL
T-cells	NULL
(	NULL
52	NULL
)	NULL
,	NULL
cellular	NULL
regulation	NULL
mechanisms	NULL
quickly	NULL
restored	NULL
the	NULL
basal	NULL
level	NULL
after	NULL
the	NULL
thiol	NULL
decrease	NULL
induced	NULL
by	NULL
CD2	NULL
and	NULL
CD28	NULL
costimulation	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
intracellular	NULL
oxidant	NULL
stress	NULL
is	NULL
one	NULL
of	NULL
the	NULL
first	NULL
phenomena	NULL
in	NULL
T-cell	NULL
activation	NULL
,	NULL
but	NULL
a	NULL
fine	NULL
balance	NULL
of	NULL
oxidoreduction	NULL
status	NULL
is	NULL
required	NULL
,	NULL
since	NULL
prolonged	NULL
oxidative	NULL
stress	NULL
is	NULL
deleteri-ous	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
the	NULL
initial	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
via	NULL
CD2+CD28	NULL
relies	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
on	NULL
a	NULL
prooxidant	NULL
state	NULL
of	NULL
peripheral	NULL
T-cells	NULL
.	NULL

A	NULL
functional	NULL
study	NULL
is	NULL
under	NULL
way	NULL
to	NULL
assess	NULL
in	NULL
more	NULL
detail	NULL
the	NULL
role	NULL
of	NULL
thiol	NULL
level	NULL
depletion	NULL
during	NULL
T-cell	NULL
stimulation	NULL
in	NULL
correlation	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

In	NULL
the	NULL
human	NULL
promyelocytic	NULL
cell	NULL
line	NULL
HL60	NULL
stimulated	NULL
by	NULL
TNF-a	NULL
or	NULL
PMA	NULL
,	NULL
maintenance	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
was	NULL
reported	NULL
to	NULL
depend	NULL
on	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
and	NULL
the	NULL
continuous	NULL
presence	NULL
of	NULL
external	NULL
stimuli	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
level	NULL
of	NULL
the	NULL
3.8-kilobase	NULL
mRNA	NULL
encoding	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
subunit	NULL
is	NULL
increased	NULL
upon	NULL
stimulation	NULL
.	NULL

Cotransfection	NULL
experiments	NULL
demonstrated	NULL
that	NULL
the	NULL
promoter	NULL
of	NULL
p50	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
either	NULL
of	NULL
the	NULL
two	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
p50	NULL
and	NULL
p65	NULL
)	NULL
and	NULL
more	NULL
strongly	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
both	NULL
(	NULL
54	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
such	NULL
a	NULL
mechanism	NULL
could	NULL
be	NULL
involved	NULL
during	NULL
long-term	NULL
CD2+CD28	NULL
stimulation	NULL
,	NULL
analysis	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
gene	NULL
family	NULL
expression	NULL
at	NULL
transcriptional	NULL
and	NULL
posttranscriptional	NULL
levels	NULL
is	NULL
under	NULL
way	NULL
.	NULL

What	NULL
Are	NULL
the	NULL
Roles	NULL
of	NULL
the	NULL
Various	NULL
«	NULL
B	NULL
Complexes	NULL
?	NULL

A	NULL
new	NULL
physiological	NULL
function	NULL
has	NULL
recently	NULL
been	NULL
suggested	NULL
for	NULL
p50	NULL
homodimers	NULL
in	NULL
the	NULL
T-cell	NULL
response	NULL
(	NULL
40	NULL
)	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
in	NULL
a	NULL
nontransformed	NULL
CD4+	NULL
T-lymphocyte	NULL
clone	NULL
,	NULL
p50	NULL
homodimers	NULL
present	NULL
in	NULL
resting	NULL
cells	NULL
seem	NULL
to	NULL
inhibit	NULL
IL-2	NULL
gene	NULL
expression	NULL
.	NULL

After	NULL
antigenic	NULL
activation	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
homodimer	NULL
decreased	NULL
,	NULL
whereas	NULL
the	NULL
amount	NULL
of	NULL
the	NULL
p50-p65	NULL
heterodimer	NULL
increased	NULL
.	NULL

In	NULL
parallel	NULL
,	NULL
induced	NULL
expression	NULL
of	NULL
the	NULL
!	NULL

L-2	NULL
gene	NULL
and	NULL
activity	NULL
of	NULL
the	NULL
IL-2	NULL
«	NULL
B-DNA	NULL
binding	NULL
site	NULL
correlated	NULL
with	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
p50-p50	NULL
complex	NULL
.	NULL

Furthermore	NULL
,	NULL
overexpression	NULL
of	NULL
p50	NULL
repressed	NULL
IL-2	NULL
promoter	NULL
activity	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
upon	NULL
CD2+CD28	NULL
stimulation	NULL
,	NULL
we	NULL
detected	NULL
an	NULL
additional	NULL
inducible	NULL
Rel-like	NULL
complex	NULL
and	NULL
no	NULL
significant	NULL
variation	NULL
in	NULL
p50-p50	NULL
amounts	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
these	NULL
discrepancies	NULL
are	NULL
due	NULL
to	NULL
differences	NULL
in	NULL
stimulation	NULL
conditions	NULL
,	NULL
«	NULL
B	NULL
probes	NULL
,	NULL
and	NULL
cell	NULL
population	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
putative	NULL
mechanism	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
action	NULL
,	NULL
CD2	NULL
and	NULL
CD28	NULL
costimulation	NULL
could	NULL
induce	NULL
sufficient	NULL
amounts	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50-p65	NULL
and	NULL
c-Rel	NULL
complexes	NULL
to	NULL
remove	NULL
p50-p50	NULL
dimer	NULL
inhibitory	NULL
block	NULL
.	NULL

Such	NULL
a	NULL
hypothesis	NULL
is	NULL
reinforced	NULL
by	NULL
the	NULL
recent	NULL
identification	NULL
of	NULL
c-Rel	NULL
as	NULL
one	NULL
component	NULL
of	NULL
the	NULL
Rel/NF-	NULL
«	NULL
B	NULL
family	NULL
proteins	NULL
involved	NULL
in	NULL
the	NULL
«	NULL
B-dependent	NULL
activation	NULL
of	NULL
!	NULL

L-2Ra	NULL
gene	NULL
expression	NULL
(	NULL
55	NULL
)	NULL
.	NULL

How	NULL
Are	NULL
the	NULL
Functional	NULL
Effects	NULL
of	NULL
PDTC	NULL
in	NULL
Human	NULL
Primary	NULL
T-Lymphocytes	NULL
Explained	NULL
?	NULL

In	NULL
agreement	NULL
with	NULL
its	NULL
blocking	NULL
effect	NULL
in	NULL
response	NULL
to	NULL
many	NULL
NF-	NULL
«	NULL
B	NULL
inducers	NULL
(	NULL
36	NULL
,	NULL
37	NULL
)	NULL
,	NULL
PDTC	NULL
inhibited	NULL
CD24+CD28	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
appearance	NULL
,	NULL
and	NULL
,	NULL
since	NULL
cell	NULL
viability	NULL
was	NULL
not	NULL
af-fected	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
PDTC	NULL
is	NULL
well	NULL
suited	NULL
for	NULL
experiments	NULL
using	NULL
primary	NULL
T-cells	NULL
.	NULL

However	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
inhibition	NULL
of	NULL
proliferation	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
a	NULL
somewhat	NULL
higher	NULL
PDTC	NULL
concentration	NULL
(	NULL
>	NULL
10	NULL
um	NULL
versus	NULL
1	NULL
um	NULL
)	NULL
was	NULL
required	NULL
to	NULL
impair	NULL
cytokine	NULL
expression	NULL
and	NULL
receptivity	NULL
.	NULL

Although	NULL
several	NULL
independent	NULL
studies	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
potential	NULL
role	NULL
for	NULL
oxidation-reduction	NULL
in	NULL
the	NULL
control	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
the	NULL
exact	NULL
mechanism	NULL
involved	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
characterized	NULL
(	NULL
36	NULL
,	NULL
38	NULL
,	NULL
56	NULL
,	NULL
57	NULL
)	NULL
.	NULL

PDTC	NULL
has	NULL
at	NULL
least	NULL
two	NULL
chemical	NULL
properties	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
its	NULL
oxygen	NULL
radical-scavenging	NULL
effect	NULL
,	NULL
PDTC	NULL
also	NULL
has	NULL
a	NULL
chelating	NULL
activity	NULL
for	NULL
heavy	NULL
metals	NULL
that	NULL
could	NULL
interfere	NULL
with	NULL
metal-dependent	NULL
enzymes	NULL
.	NULL

Both	NULL
mechanisms	NULL
seem	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
Jurkat	NULL
T-cells	NULL
treated	NULL
by	NULL
several	NULL
inducers	NULL
,	NULL
such	NULL
as	NULL
H	NULL
;	NULL
O	NULL
;	NULL
,	NULL
PMA	NULL
,	NULL
or	NULL
TNF-a	NULL
(	NULL
37	NULL
)	NULL
.	NULL

However	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
inhibition	NULL
required	NULL
considerably	NULL
lower	NULL
PDTC	NULL
concentrations	NULL
(	NULL
1	NULL
um	NULL
versus	NULL
100	NULL
gm	NULL
)	NULL
in	NULL
primary	NULL
T-cells	NULL
than	NULL
in	NULL
the	NULL
tumoral	NULL
Jurkat	NULL
T-cell	NULL
line	NULL
(	NULL
Ref	NULL
.	NULL

37	NULL
and	NULL
this	NULL
report	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
did	NULL
not	NULL
observe	NULL
desensitization	NULL
to	NULL
the	NULL
drug	NULL
,	NULL
as	NULL
reported	NULL
in	NULL
Jurkat	NULL
T-cells	NULL
(	NULL
37	NULL
)	NULL
,	NULL
but	NULL
a	NULL
high	NULL
cell	NULL
toxicity	NULL
above	NULL
100	NULL
am	NULL
PDTC	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
inhibition	NULL
did	NULL
not	NULL
require	NULL
prein-cubation	NULL
,	NULL
as	NULL
inhibitor	NULL
and	NULL
inducers	NULL
were	NULL
added	NULL
simultaneously	NULL
in	NULL
our	NULL
experiments	NULL
.	NULL

Our	NULL
observations	NULL
are	NULL
one	NULL
more	NULL
example	NULL
of	NULL
differences	NULL
between	NULL
the	NULL
tumor	NULL
cell	NULL
line	NULL
and	NULL
the	NULL
primary	NULL
T-cell	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
the	NULL
observed	NULL
discrepancies	NULL
are	NULL
due	NULL
to	NULL
differences	NULL
in	NULL
experimental	NULL
conditions	NULL
in	NULL
which	NULL
,	NULL
on	NULL
one	NULL
hand	NULL
,	NULL
the	NULL
drug	NULL
was	NULL
added	NULL
to	NULL
actively	NULL
dividing	NULL
cells	NULL
and	NULL
,	NULL
on	NULL
the	NULL
other	NULL
,	NULL
to	NULL
resting	NULL
T-cells	NULL
before	NULL
the	NULL
CD2+CD28-triggered	NULL
Go-G	NULL
:	NULL
transition	NULL
.	NULL

Furthermore	NULL
,	NULL
upon	NULL
simultaneous	NULL
addition	NULL
of	NULL
inducers	NULL
and	NULL
inhibitor	NULL
,	NULL
enough	NULL
active	NULL
NF-	NULL
«	NULL
B	NULL
could	NULL
be	NULL
transiently	NULL
present	NULL
in	NULL
the	NULL
nucleus	NULL
and	NULL
participate	NULL
in	NULL
cytokine	NULL
and	NULL
receptor	NULL
gene	NULL
induction	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hypothesis	NULL
,	NULL
further	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
337	NULL
experiments	NULL
are	NULL
necessary	NULL
to	NULL
determine	NULL
NF-	NULL
«	NULL
B	NULL
half-life	NULL
and	NULL
turnover	NULL
rate	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
although	NULL
our	NULL
data	NULL
support	NULL
the	NULL
involvement	NULL
of	NULL
oxidative	NULL
stress	NULL
and	NULL
the	NULL
requirement	NULL
of	NULL
NF-kB	NULL
maintenance	NULL
for	NULL
long-term	NULL
primary	NULL
T-cell	NULL
proliferation	NULL
,	NULL
they	NULL
also	NULL
suggest	NULL
the	NULL
engagement	NULL
of	NULL
other	NULL
regulatory	NULL
factors	NULL
.	NULL

Consequently	NULL
,	NULL
further	NULL
experiments	NULL
are	NULL
required	NULL
to	NULL
assess	NULL
the	NULL
role	NULL
of	NULL
the	NULL
different	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
identified	NULL
and	NULL
their	NULL
interactions	NULL
with	NULL
other	NULL
trans-acting	NULL
factors	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
cytokine	NULL
and	NULL
receptor	NULL
genes	NULL
through	NULL
activation	NULL
of	NULL
CD2	NULL
and	NULL
CD28	NULL
.	NULL

These	NULL
studies	NULL
may	NULL
provide	NULL
new	NULL
and	NULL
important	NULL
insights	NULL
into	NULL
the	NULL
mechanisms	NULL
of	NULL
the	NULL
adhesion	NULL
molecule	NULL
pathway	NULL
involved	NULL
in	NULL
normal	NULL
T-cell	NULL
growth	NULL
and	NULL
differentiation	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Primary	NULL
T-Lymphocyte	NULL
Preparation	NULL
.	NULL

Peripheral	NULL
blood	NULL
lymphocytes	NULL
were	NULL
isolated	NULL
from	NULL
healthy	NULL
blood	NULL
donors	NULL
,	NULL
and	NULL
T-cells	NULL
were	NULL
purified	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Controls	NULL
for	NULL
the	NULL
absence	NULL
of	NULL
monocytic	NULL
,	NULL
B-	NULL
,	NULL
and	NULL
natural	NULL
killer	NULL
cell	NULL
contamination	NULL
were	NULL
performed	NULL
by	NULL
flow	NULL
cytometry	NULL
analysis	NULL
using	NULL
specific	NULL
fluorescein	NULL
isothiocyanate-labeled	NULL
mAbs	NULL
,	NULL
namely	NULL
10G3.3	NULL
(	NULL
CD14	NULL
)	NULL
,	NULL
10B4	NULL
(	NULL
CD19	NULL
;	NULL
Immunotech	NULL
,	NULL
Marseille	NULL
,	NULL
France	NULL
)	NULL
,	NULL
and	NULL
NKH1	NULL
(	NULL
Coulter	NULL
Electronics	NULL
,	NULL
Hialeah	NULL
,	NULL
FL	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Contamination	NULL
by	NULL
B-	NULL
or	NULL
natural	NULL
killer	NULL
cells	NULL
was	NULL
less	NULL
than	NULL
1	NULL
%	NULL
.	NULL

Preparations	NULL
were	NULL
considered	NULL
to	NULL
be	NULL
depleted	NULL
of	NULL
monocytes	NULL
when	NULL
less	NULL
than	NULL
1	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
labeled	NULL
with	NULL
10G3.3	NULL
mAb	NULL
and	NULL
when	NULL
no	NULL
proliferation	NULL
was	NULL
observed	NULL
upon	NULL
optimal	NULL
stimulation	NULL
with	NULL
either	NULL
PHA	NULL
or	NULL
soluble	NULL
CD3	NULL
mAb	NULL
.	NULL

Induction	NULL
Conditions	NULL
.	NULL

Stimulations	NULL
were	NULL
performed	NULL
with	NULL
different	NULL
mAbs	NULL
used	NULL
at	NULL
saturating	NULL
concentrations	NULL
:	NULL
mAb	NULL
39C1.5	NULL
(	NULL
rat	NULL
1gG2a	NULL
,	NULL
anti-CD2	NULL
)	NULL
in	NULL
combination	NULL
with	NULL
6F10.3	NULL
(	NULL
mouse	NULL
1IgG1	NULL
,	NULL
anti-CD2	NULL
)	NULL
,	NULL
mAb	NULL
248	NULL
(	NULL
mouse	NULL
IgM	NULL
,	NULL
anti-CD28	NULL
)	NULL
,	NULL
and	NULL
mAb	NULL
289	NULL
(	NULL
mouse	NULL
IgG2a	NULL
,	NULL
anti-CD3	NULL
)	NULL
,	NULL
obtained	NULL
from	NULL
Dr.	NULL
A.	NULL
Moretta	NULL
,	NULL
Cancer	NULL
Institute	NULL
,	NULL
Genoa	NULL
,	NULL
Italy	NULL
.	NULL

CO2	NULL
mAb	NULL
was	NULL
used	NULL
as	NULL
purified	NULL
mAb	NULL
at	NULL
10	NULL
ug/ml	NULL
,	NULL
CD28	NULL
mAb	NULL
ascitic	NULL
fluid	NULL
was	NULL
used	NULL
at	NULL
a	NULL
1/400	NULL
dilution	NULL
,	NULL
and	NULL
CD3	NULL
mAb	NULL
was	NULL
coated	NULL
(	NULL
CD3c	NULL
)	NULL
onto	NULL
plates	NULL
.	NULL

TPA	NULL
(	NULL
Sigma	NULL
)	NULL
was	NULL
added	NULL
at	NULL
a	NULL
submitogenic	NULL
concentration	NULL
(	NULL
107°	NULL
m	NULL
)	NULL
when	NULL
mentioned	NULL
in	NULL
figure	NULL
legends	NULL
.	NULL

Proliferation	NULL
Assay	NULL
.	NULL

Purified	NULL
T-cells	NULL
(	NULL
20,000/well	NULL
)	NULL
were	NULL
grown	NULL
in	NULL
flat-bottomed	NULL
96-well	NULL
microtiter	NULL
plates	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
200	NULL
ul	NULL
of	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
and	NULL
[	NULL
PHJthymidine	NULL
(	NULL
Amersham	NULL
)	NULL
was	NULL
added	NULL
(	NULL
1.74	NULL
kBq/well	NULL
)	NULL
for	NULL
18	NULL
h.	NULL
Cells	NULL
were	NULL
then	NULL
harvested	NULL
on	NULL
Whatman	NULL
filters	NULL
and	NULL
analyzed	NULL
by	NULL
liquid	NULL
scintillation	NULL
counting	NULL
.	NULL

All	NULL
assays	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

Assays	NULL
for	NULL
Cytokine	NULL
Production	NULL
and	NULL
Soluble	NULL
IL-2	NULL
Receptor	NULL
.	NULL

IL-2	NULL
secretion	NULL
was	NULL
determined	NULL
by	NULL
ELISA	NULL
assay	NULL
(	NULL
Immunotech	NULL
;	NULL
limit	NULL
of	NULL
detection	NULL
less	NULL
than	NULL
30	NULL
pg/ml	NULL
)	NULL
.	NULL

GM-CSF	NULL
secretion	NULL
was	NULL
determined	NULL
by	NULL
ELISA	NULL
assay	NULL
(	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
J.	NULL
Abrams	NULL
,	NULL
DNAX	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
;	NULL
limit	NULL
of	NULL
detection	NULL
50	NULL
pg/ml	NULL
)	NULL
.	NULL

Soluble	NULL
IL-2	NULL
receptor	NULL
was	NULL
dosed	NULL
using	NULL
an	NULL
ELISA	NULL
assay	NULL
with	NULL
a	NULL
5-pm	NULL
limit	NULL
of	NULL
detection	NULL
(	NULL
Immunotech	NULL
)	NULL
.	NULL

Flow	NULL
Cytometry	NULL
.	NULL

CD25/IL-2Ra	NULL
cell	NULL
surface	NULL
expression	NULL
was	NULL
detected	NULL
according	NULL
to	NULL
standard	NULL
procedures	NULL
with	NULL
fluorescein	NULL
isothiocyanate-labeled	NULL
antibody	NULL
33B3.1	NULL
(	NULL
58	NULL
)	NULL
using	NULL
a	NULL
FACSCAN	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

Thiol	NULL
Level	NULL
Assessment	NULL
.	NULL

Levels	NULL
of	NULL
thiols	NULL
and	NULL
glutathione	NULL
were	NULL
evaluated	NULL
according	NULL
to	NULL
Rice	NULL
et	NULL
al	NULL
.	NULL

and	NULL
Staal	NULL
et	NULL
al	NULL
.	NULL

(	NULL
38	NULL
)	NULL
with	NULL
slight	NULL
modifications	NULL
.	NULL

Cells	NULL
(	NULL
10°/ml	NULL
)	NULL
were	NULL
stained	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
15	NULL
min	NULL
with	NULL
monochlo-	NULL
robimane	NULL
(	NULL
Molecular	NULL
Probes	NULL
)	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
10	NULL
um	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
stopped	NULL
by	NULL
addition	NULL
of	NULL
3	NULL
ml	NULL
of	NULL
ice-cold	NULL
staining	NULL
medium	NULL
and	NULL
centrifuged	NULL
through	NULL
0.5	NULL
ml	NULL
of	NULL
underlaid	NULL
serum	NULL
to	NULL
remove	NULL
unreacted	NULL
MCB	NULL
.	NULL

Samples	NULL
were	NULL
washed	NULL
twice	NULL
and	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
(	NULL
ATC	NULL
3000	NULL
;	NULL
Odam	NULL
)	NULL
with	NULL
70	NULL
mW	NULL
UV	NULL
light	NULL
and	NULL
525-nm	NULL
filter	NULL
.	NULL

Preparation	NULL
of	NULL
Nuclear	NULL
Extracts	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
essentially	NULL
according	NULL
to	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

(	NULL
59	NULL
)	NULL
as	NULL
modified	NULL
by	NULL
Staal	NULL
et	NULL
al	NULL
.	NULL

(	NULL
38	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
washed	NULL
in	NULL
cold	NULL
Tris-buffered	NULL
saline	NULL
,	NULL
then	NULL
resuspended	NULL
in	NULL
0.4	NULL
ml	NULL
of	NULL
buffer	NULL
A	NULL
[	NULL
10	NULL
mm	NULL
4-	NULL
(	NULL
2-hydroxyethyl	NULL
)	NULL
-1-piperazineethanesulfonic	NULL
acid	NULL
,	NULL
pH	NULL
7.8-10	NULL
mm	NULL
KCl-2	NULL
mm	NULL
MgCl	NULL
;	NULL
-1	NULL
mm	NULL
dithiothreitol-0.1	NULL
mm	NULL
EDTA-0.1	NULL
mm	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
]	NULL
supplemented	NULL
with	NULL
leu-peptin	NULL
(	NULL
0.3	NULL
mg/ml	NULL
;	NULL
Sigma	NULL
)	NULL
,	NULL
and	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Then	NULL
25	NULL
gl	NULL
of	NULL
a	NULL
10	NULL
%	NULL
Nonidet	NULL
P-40	NULL
solution	NULL
(	NULL
Sigma	NULL
)	NULL
were	NULL
added	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
vigorously	NULL
mixed	NULL
for	NULL
15	NULL
s	NULL
and	NULL
then	NULL
centrifuged	NULL
(	NULL
13,000	NULL
rpm	NULL
,	NULL
15	NULL
s	NULL
)	NULL
.	NULL

Pelleted	NULL
nuclei	NULL
were	NULL
resuspended	NULL
in	NULL
50	NULL
ul	NULL
of	NULL
buffer	NULL
C	NULL
[	NULL
50	NULL
mm	NULL
4-	NULL
(	NULL
2-hydroxyethyl	NULL
)	NULL
-1-piperazineethanesulfonic	NULL
acid	NULL
,	NULL
pH	NULL
7.8-50	NULL
mm	NULL
KCIl-300	NULL
mm	NULL
NaCl-0.1	NULL
mm	NULL
EDTA-1	NULL
mm	NULL
dithiothreitol-0.1	NULL
mm	NULL
phenyImethylsulfonyl	NULL
fluoride	NULL
10	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
glyc-erol	NULL
]	NULL
.	NULL

After	NULL
mixing	NULL
for	NULL
20	NULL
min	NULL
,	NULL
the	NULL
nuclei	NULL
were	NULL
centrifuged	NULL
for	NULL
5	NULL
min	NULL
at	NULL
13,000	NULL
rpm	NULL
,	NULL
and	NULL
supernatants	NULL
containing	NULL
the	NULL
nuclear	NULL
proteins	NULL
were	NULL
transferred	NULL
to	NULL
another	NULL
tube	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
measured	NULL
with	NULL
a	NULL
commercial	NULL
kit	NULL
(	NULL
Bio-Rad	NULL
)	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Bradford	NULL
(	NULL
60	NULL
)	NULL
.	NULL

Oligonucleotides	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
oligonucieo-tides	NULL
were	NULL
as	NULL
follows	NULL
.	NULL

(	NULL
a	NULL
)	NULL
«	NULL
B.	NULL
,	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
of	NULL
the	NULL
mouse	NULL
Ig	NULL
«	NULL
light	NULL
chain	NULL
enhancer	NULL
)	NULL
(	NULL
17	NULL
)	NULL
5	NULL
'	NULL
-	NULL
TCGACAGAGGGGACTTTCCGAGAGGCTCGA	NULL
-	NULL
3	NULL
'	NULL
3	NULL
``	NULL
-	NULL
AGCTGTCTCCCCTGAAAGGCTCTCCGAGCT-5	NULL
'	NULL
(	NULL
b	NULL
)	NULL
m	NULL
«	NULL
Bug	NULL
(	NULL
mutant	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
of	NULL
the	NULL
mouse	NULL
Ig	NULL
light	NULL
chain	NULL
enhancer	NULL
)	NULL
(	NULL
17	NULL
)	NULL
5	NULL
'	NULL
-	NULL
TCGACAGAATTCACTTTCCGAGAGGCTCGA	NULL
-	NULL
3	NULL
'	NULL
3	NULL
``	NULL
-	NULL
AGCTGTCTTAAGTGAAAGGCTCTCCGAGCT	NULL
-	NULL
5	NULL
(	NULL
c	NULL
)	NULL
«	NULL
Bi	NULL
.	NULL

;	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
)	NULL
(	NULL
22	NULL
)	NULL
5	NULL
``	NULL
-	NULL
ACAAAGAGGGATTTCACCTACATCCAT	NULL
-	NULL
3	NULL
'	NULL
3	NULL
'	NULL
-	NULL
TGTTTCTCCCTAAAGTGGATGTAGGTA-5	NULL
'	NULL
(	NULL
d	NULL
)	NULL
«	NULL
Bu.sr	NULL
,	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
of	NULL
the	NULL
IL-2Ra	NULL
promoter	NULL
)	NULL
(	NULL
22	NULL
)	NULL
5	NULL
``	NULL
-	NULL
CAACGGCAGGGGAATCTCCCTCTCCTT-3	NULL
'	NULL
3	NULL
``	NULL
-GTTGCCGTCCCCTTAGAGGGAGAGGAA	NULL
-	NULL
5	NULL
``	NULL
{	NULL
e	NULL
)	NULL
«	NULL
Biu	NULL
,	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
of	NULL
the	NULL
!	NULL

L-6	NULL
promoter	NULL
)	NULL
(	NULL
22	NULL
)	NULL
5°	NULL
-	NULL
ATCAAATGTGGGATTTTCCCATGAGTC-3	NULL
'	NULL
3	NULL
'	NULL
-	NULL
TAGTTTACACCCTAAAAGGGTACTCAG-5	NULL
'	NULL
(	NULL
f	NULL
)	NULL
SP1svao	NULL
(	NULL
SP1	NULL
binding	NULL
site	NULL
from	NULL
the	NULL
SV40	NULL
early	NULL
promoter	NULL
)	NULL
(	NULL
61	NULL
)	NULL
5	NULL
``	NULL
-	NULL
CGATGGGCGGAGTTAGGGACGGGA	NULL
-	NULL
3	NULL
'	NULL
3	NULL
``	NULL
-TACCCGCCTCAATCCCTGCCCTGC-	NULL
5	NULL
Specific	NULL
Antisera	NULL
and	NULL
Recombinant	NULL
Protein	NULL
.	NULL

Rabbit	NULL
sera	NULL
no	NULL
.	NULL

2	NULL
and	NULL
no	NULL
.	NULL

3	NULL
(	NULL
46	NULL
)	NULL
are	NULL
against	NULL
fusion	NULL
proteins	NULL
338	NULL
|	NULL
NF-	NULL
«	NULL
B	NULL
Activation	NULL
in	NULL
CD2+CD28-stimulated	NULL
Primary	NULL
T-Cells	NULL
containing	NULL
amino	NULL
acids	NULL
19-969	NULL
and	NULL
19-502	NULL
of	NULL
KBF1	NULL
p50	NULL
,	NULL
respectively	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
A.	NULL
Israel	NULL
,	NULL
U277	NULL
INSERM	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
.	NULL

Antiserum	NULL
no	NULL
.	NULL

2	NULL
recognizes	NULL
both	NULL
KBF1/	NULL
p50	NULL
homodimer	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
p50-p65	NULL
heterodimer	NULL
.	NULL

Antiserum	NULL
no	NULL
.	NULL

3	NULL
recognizes	NULL
only	NULL
KBF1/p50	NULL
homodimer	NULL
.	NULL

Antisera	NULL
to	NULL
recombinant	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
c-Rel	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
R.	NULL
Bravo	NULL
(	NULL
Bristol	NULL
Myers	NULL
Squibb	NULL
,	NULL
Princeton	NULL
,	NULL
NJ	NULL
)	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Bacterial	NULL
extract	NULL
containing	NULL
MAD-3/ixB*	NULL
was	NULL
obtained	NULL
from	NULL
T.	NULL
Henkel	NULL
(	NULL
Laboratorium	NULL
fur	NULL
Molekulare	NULL
Biologie	NULL
,	NULL
Genzentrum	NULL
,	NULL
Martinsried	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
.	NULL

Oligonucleotides	NULL
were	NULL
labeled	NULL
using	NULL
[	NULL
1+-	NULL
>	NULL
P	NULL
]	NULL
ATP	NULL
and	NULL
polynucleotide	NULL
kinase	NULL
,	NULL
annealed	NULL
,	NULL
and	NULL
gel	NULL
purified	NULL
for	NULL
isolation	NULL
of	NULL
double-stranded	NULL
probes	NULL
.	NULL

Reactions	NULL
with	NULL
equal	NULL
amounts	NULL
of	NULL
nuclear	NULL
extracts	NULL
(	NULL
1	NULL
ug/reaction	NULL
)	NULL
were	NULL
performed	NULL
in	NULL
a	NULL
20-ul	NULL
final	NULL
volume	NULL
containing	NULL
approximately	NULL
50,000	NULL
cpm	NULL
probe	NULL
,	NULL
0.25	NULL
ug	NULL
polydeoxyinosinic-deoxycytidylic	NULL
acid	NULL
,	NULL
and	NULL
20	NULL
ug	NULL
bovine	NULL
serum	NULL
albumin	NULL
.	NULL

Extracts	NULL
in	NULL
buffer	NULL
C	NULL
were	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
the	NULL
probe	NULL
.	NULL

Reaction	NULL
mixtures	NULL
were	NULL
then	NULL
loaded	NULL
on	NULL
5	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
0.25	NULL
%	NULL
TBE	NULL
(	NULL
1	NULL
%	NULL
TBE	NULL
=	NULL
89	NULL
mm	NULL
Tris-89	NULL
mm	NULL
boric	NULL
acid-1	NULL
mm	NULL
EDTA	NULL
)	NULL
.	NULL

After	NULL
electro-phoresis	NULL
,	NULL
dried	NULL
gels	NULL
were	NULL
exposed	NULL
at	NULL
-80°C	NULL
to	NULL
Kodak	NULL
XR5	NULL
film	NULL
on	NULL
intensifying	NULL
screens	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

For	NULL
competition	NULL
assays	NULL
,	NULL
unlabeled	NULL
complementary	NULL
oligonucleotides	NULL
were	NULL
gel	NULL
purified	NULL
after	NULL
annealing	NULL
.	NULL

Unlabeled	NULL
com-petitor	NULL
,	NULL
specific	NULL
antiserum	NULL
,	NULL
or	NULL
recombinant	NULL
protein	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
mixture	NULL
just	NULL
before	NULL
adding	NULL
the	NULL
radiolabeled	NULL
probe	NULL
.	NULL

DNA-Protein	NULL
Cross-Linking	NULL
Studies	NULL
.	NULL

Photoreactive	NULL
P-labeled	NULL
«	NULL
Biu	NULL
.	NULL

»	NULL
r	NULL
,	NULL
probe	NULL
was	NULL
prepared	NULL
by	NULL
annealing	NULL
the	NULL
coding	NULL
strand	NULL
template	NULL
to	NULL
the	NULL
complementary	NULL
10-base	NULL
primer	NULL
(	NULL
5	NULL
(	NULL
-GGGAGAGGAA-3	NULL
'	NULL
)	NULL
and	NULL
filling	NULL
in	NULL
the	NULL
overhang	NULL
with	NULL
Klenow	NULL
polymerase	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
a-P	NULL
]	NULL
dATP	NULL
and	NULL
dCTP	NULL
,	NULL
dGTP	NULL
,	NULL
and	NULL
equimolar	NULL
amounts	NULL
of	NULL
TTP	NULL
and	NULL
5-bromo-2'-deoxyuridine	NULL
5'-triphosphate	NULL
.	NULL

Wet	NULL
polyacrylamide	NULL
gels	NULL
from	NULL
EMSA	NULL
were	NULL
placed	NULL
on	NULL
a	NULL
312-nm	NULL
UV	NULL
transilluminator	NULL
(	NULL
Bioblock	NULL
Scientific	NULL
;	NULL
8000	NULL
«	NULL
W/	NULL
cm	NULL
'	NULL
)	NULL
.	NULL

After	NULL
autoradiography	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
gel	NULL
slices	NULL
corresponding	NULL
to	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
excised	NULL
,	NULL
eluted	NULL
in	NULL
reducing	NULL
buffer	NULL
,	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
on	NULL
10	NULL
%	NULL
polyacrylamide-sodium	NULL
dodecyl	NULL
sulfate	NULL
gels	NULL
(	NULL
62	NULL
)	NULL
.	NULL

Acknowledgments	NULL
The	NULL
authors	NULL
would	NULL
like	NULL
to	NULL
thank	NULL
Drs	NULL
.	NULL

Alain	NULL
Israél	NULL
and	NULL
Rodrigo	NULL
Bravo	NULL
for	NULL
providing	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
antisera	NULL
,	NULL
Remy	NULL
Galindo	NULL
and	NULL
Christine	NULL
Pavon	NULL
for	NULL
helpful	NULL
technical	NULL
assistance	NULL
,	NULL
and	NULL
Drs	NULL
.	NULL

Claude	NULL
Mawas	NULL
,	NULL
Alain	NULL
Israél	NULL
,	NULL
Jean-Marie	NULL
Blanchard	NULL
,	NULL
and	NULL
Manuela	NULL
Urban	NULL
for	NULL
invaluable	NULL
advice	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Selvaraj	NULL
,	NULL
P.	NULL
,	NULL
Plunkett	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Dustin	NULL
,	NULL
M.	NULL
,	NULL
Sanders	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Shaw	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Springer	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

The	NULL
T	NULL
lymphocyte	NULL
glycoprotein	NULL
CD2	NULL
binds	NULL
the	NULL
cell	NULL
surface	NULL
ligand	NULL
LFA-3	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
326	NULL
:	NULL
400-403	NULL
,	NULL
1987	NULL
.	NULL

2	NULL
.	NULL

Damle	NULL
,	NULL
N.	NULL
K.	NULL
,	NULL
Mohagheghpour	NULL
,	NULL
N.	NULL
,	NULL
Hansen	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Engleman	NULL
,	NULL
E.	NULL
G.	NULL
Alloantigen-specific	NULL
cytotoxic	NULL
and	NULL
suppressor	NULL
T	NULL
lymphocytes	NULL
are	NULL
derived	NULL
from	NULL
phenotypically	NULL
distinct	NULL
precursors	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
131	NULL
:	NULL
2296-2300	NULL
,	NULL
1983	NULL
.	NULL

3	NULL
.	NULL

Clark	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Holly	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Dinndorf	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Shu	NULL
,	NULL
G.	NULL
Polypeptides	NULL
on	NULL
human	NULL
B	NULL
lymphocytes	NULL
associated	NULL
with	NULL
cell	NULL
activation	NULL
.	NULL

Hum	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
16	NULL
:	NULL
100-113	NULL
,	NULL
1986	NULL
.	NULL

4	NULL
.	NULL

Freeman	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
Freedman	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Segil	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Lee	NULL
,	NULL
G.	NULL
,	NULL
Whitman	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
and	NULL
Nadler	NULL
,	NULL
L.	NULL
M.	NULL
87	NULL
,	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
ig	NULL
superfamily	NULL
with	NULL
unique	NULL
expression	NULL
on	NULL
activated	NULL
and	NULL
neoplastic	NULL
B	NULL
cells	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
143	NULL
:	NULL
2714-2722	NULL
,	NULL
1989	NULL
.	NULL

5	NULL
.	NULL

Linsley	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Clark	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
and	NULL
Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
T-cell	NULL
antigen	NULL
CD28	NULL
mediates	NULL
adhesion	NULL
with	NULL
B	NULL
cells	NULL
by	NULL
interacting	NULL
with	NULL
activation	NULL
antigen	NULL
B7/	NULL
BB-1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
87	NULL
:	NULL
5031-5035	NULL
,	NULL
1990	NULL
.	NULL

6	NULL
.	NULL

Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Martin	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Spooner	NULL
,	NULL
C.	NULL
E.	NULL
,	NULL
Wofsi	NULL
,	NULL
D.	NULL
,	NULL
Tsu	NULL
,	NULL
T.	NULL
T.	NULL
,	NULL
Beatty	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
and	NULL
Gladstone	NULL
,	NULL
P.	NULL
Antibodies	NULL
to	NULL
Tp67	NULL
and	NULL
Tp44	NULL
augment	NULL
and	NULL
sustain	NULL
proliferative	NULL
responses	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
135	NULL
:	NULL
2331-2336	NULL
,	NULL
1985	NULL
.	NULL

7	NULL
.	NULL

Meuer	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Hodgdon	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Hussey	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Protentis	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Schlossman	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
and	NULL
Reinherz	NULL
,	NULL
E.	NULL
L.	NULL
Antigen-like	NULL
effects	NULL
of	NULL
monoclonal	NULL
antibodies	NULL
directed	NULL
at	NULL
receptors	NULL
on	NULL
human	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
158	NULL
;	NULL
988-993	NULL
,	NULL
1983	NULL
.	NULL

8	NULL
.	NULL

Meuer	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Hussey	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Fabbi	NULL
,	NULL
M.	NULL
,	NULL
Fox	NULL
,	NULL
D.	NULL
,	NULL
Acuto	NULL
,	NULL
O.	NULL
,	NULL
Fitzgerald	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Hodgdon	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Protentis	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Schlossman	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
and	NULL
Reinherz	NULL
,	NULL
E.	NULL
L.	NULL
An	NULL
alternative	NULL
pathway	NULL
of	NULL
T-cell	NULL
activation	NULL
:	NULL
a	NULL
functional	NULL
role	NULL
for	NULL
the	NULL
50	NULL
kd	NULL
T11	NULL
sheep	NULL
erythrocyte	NULL
receptor	NULL
protein	NULL
.	NULL

Cell	NULL
,	NULL
36	NULL
:	NULL
897-906	NULL
,	NULL
1984	NULL
.	NULL

9	NULL
.	NULL

Pierres	NULL
,	NULL
A.	NULL
,	NULL
Lopez	NULL
,	NULL
M.	NULL
,	NULL
Cerdan	NULL
,	NULL
C.	NULL
,	NULL
Nunes	NULL
,	NULL
J.	NULL
,	NULL
Olive	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Mawas	NULL
,	NULL
C.	NULL
Triggering	NULL
CD28	NULL
molecules	NULL
synergize	NULL
with	NULL
CD2	NULL
(	NULL
T11.1	NULL
and	NULL
T11.2	NULL
)	NULL
-mediated	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Eur	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
18	NULL
:	NULL
685-690	NULL
,	NULL
1988	NULL
.	NULL

10	NULL
.	NULL

Van-Lier	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Brouwer	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Aarden	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

Signals	NULL
involved	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
:	NULL
T	NULL
cell	NULL
proliferation	NULL
induced	NULL
through	NULL
the	NULL
synergistic	NULL
action	NULL
of	NULL
anti-C	NULL
D28	NULL
and	NULL
anti-CD2	NULL
monoclonal	NULL
antibodies	NULL
.	NULL

Eur	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
18	NULL
:	NULL
167-172	NULL
,	NULL
1988	NULL
.	NULL

11	NULL
.	NULL

Cerdan	NULL
,	NULL
C.	NULL
,	NULL
Martin	NULL
,	NULL
Y.	NULL
,	NULL
Courcoul	NULL
,	NULL
M.	NULL
,	NULL
Mawas	NULL
,	NULL
C.	NULL
,	NULL
Birg	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Olive	NULL
,	NULL
D.	NULL
Prolonged	NULL
IL-2	NULL
receptor	NULL
a/CD25	NULL
expression	NULL
after	NULL
T	NULL
cell	NULL
activation	NULL
via	NULL
the	NULL
adhesion	NULL
molecules	NULL
CD2	NULL
and	NULL
CD28	NULL
:	NULL
demonstration	NULL
of	NULL
combined	NULL
transcriptional	NULL
and	NULL
post	NULL
transcriptional	NULL
regulation	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
149	NULL
:	NULL
2255-2261	NULL
,	NULL
1992	NULL
.	NULL

12	NULL
.	NULL

Lindsten	NULL
,	NULL
T.	NULL
,	NULL
June	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Ledbetter	NULL
,	NULL
}	NULL
.	NULL

A.	NULL
,	NULL
Stella	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Thompson	NULL
,	NULL
C.	NULL
B	NULL
.	NULL

Regulation	NULL
of	NULL
lymphokine	NULL
mRNA	NULL
stability	NULL
by	NULL
a	NULL
surface-mediated	NULL
T	NULL
cell	NULL
activation	NULL
pathway	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
244	NULL
:	NULL
339-343	NULL
,	NULL
1989	NULL
.	NULL

13	NULL
.	NULL

Fraser	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Irving	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

Regulation	NULL
of	NULL
interleukin-2	NULL
gene	NULL
enhancer	NULL
activity	NULL
by	NULL
the	NULL
T	NULL
cell	NULL
accessory	NULL
molecule	NULL
CD28	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
251	NULL
:	NULL
313-316	NULL
,	NULL
1991	NULL
.	NULL

14	NULL
.	NULL

Verweij	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Geerts	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Aarden	NULL
,	NULL
L.	NULL
A.	NULL
Activation	NULL
of	NULL
interleukin-2	NULL
gene	NULL
transcription	NULL
via	NULL
the	NULL
T-cell	NULL
surface	NULL
molecule	NULL
CD28	NULL
is	NULL
mediated	NULL
through	NULL
an	NULL
NF-	NULL
«	NULL
B-like	NULL
response	NULL
element	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
266	NULL
:	NULL
14179-14182	NULL
,	NULL
1991	NULL
.	NULL

15	NULL
.	NULL

Muegge	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Durum	NULL
,	NULL
S.	NULL
K.	NULL
From	NULL
cell	NULL
code	NULL
to	NULL
gene	NULL
code	NULL
:	NULL
cytokines	NULL
and	NULL
transcription	NULL
factors	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

,	NULL
1	NULL
:	NULL
239-247	NULL
,	NULL
1989	NULL
.	NULL

16	NULL
.	NULL

Grilli	NULL
,	NULL
M.	NULL
,	NULL
Chiu	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Rel-participants	NULL
in	NULL
a	NULL
multiform	NULL
transcriptional	NULL
regulatory	NULL
system	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
in	NULL
press	NULL
,	NULL
1992	NULL
.	NULL

17	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
Inducibility	NULL
of	NULL
x	NULL
immunoglobulin	NULL
enhancer-binding	NULL
protein	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
a	NULL
posttranslational	NULL
mechanism	NULL
.	NULL

Cell	NULL
,	NULL
47	NULL
:	NULL
921-928	NULL
,	NULL
1986	NULL
.	NULL

18	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

The	NULL
inducible	NULL
transcription	NULL
activator	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
regulation	NULL
by	NULL
distinct	NULL
protein	NULL
subunits	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
,	NULL
1072	NULL
:	NULL
63-80	NULL
,	NULL
1991	NULL
.	NULL

19	NULL
.	NULL

Gilmore	NULL
,	NULL
T.	NULL
D.	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
KBF1	NULL
,	NULL
dorsal	NULL
,	NULL
and	NULL
related	NULL
matters	NULL
.	NULL

Cell	NULL
,	NULL
62	NULL
:	NULL
841-843	NULL
,	NULL
1990	NULL
.	NULL

20	NULL
.	NULL

Blank	NULL
,	NULL
V.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Israel	NULL
,	NULL
A.	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
related	NULL
proteins	NULL
:	NULL
Rel/dorsal	NULL
homologies	NULL
meet	NULL
ankyrin-like	NULL
repeats	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

,	NULL
17	NULL
:	NULL
135-140	NULL
,	NULL
1992	NULL
.	NULL

21	NULL
.	NULL

Tong-Starksen	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Luciw	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Peterlin	NULL
,	NULL
B.	NULL
M.	NULL
Signaling	NULL
through	NULL
T	NULL
lymphocyte	NULL
surface	NULL
proteins	NULL
,	NULL
TCR/CD3	NULL
and	NULL
CD28	NULL
,	NULL
activates	NULL
the	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
142	NULL
;	NULL
702-707	NULL
,	NULL
1989	NULL
.	NULL

22	NULL
.	NULL

Molitor	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Walker	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
Doerre	NULL
,	NULL
S.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
a	NULL
family	NULL
of	NULL
inducible	NULL
and	NULL
differentially	NULL
expressed	NULL
enhancer-binding	NULL
proteins	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
87	NULL
:	NULL
10028-10032	NULL
,	NULL
1990	NULL
.	NULL

23	NULL
.	NULL

Arima	NULL
,	NULL
N.	NULL
,	NULL
Kuziel	NULL
,	NULL
W.	NULL
A.	NULL
,	NULL
Grdina	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
IL-2-induced	NULL
signal	NULL
transduction	NULL
involves	NULL
the	NULL
activation	NULL
of	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
expression	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
149	NULL
;	NULL
83-91	NULL
,	NULL
1992	NULL
.	NULL

24	NULL
.	NULL

Schmitz	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Henkel	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
Proteins	NULL
controlling	NULL
the	NULL
nuclear	NULL
uptake	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
Rel	NULL
and	NULL
dorsal	NULL
.	NULL

Trends	NULL
Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
1	NULL
:	NULL
130-137	NULL
,	NULL
1992	NULL
.	NULL

25	NULL
.	NULL

Haskill	NULL
,	NULL
S.	NULL
,	NULL
Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Tompkins	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Morris	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Yurochko	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Sampson-Johannes	NULL
,	NULL
A.	NULL
,	NULL
Mondal	NULL
,	NULL
K.	NULL
,	NULL
Ralph	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
J	NULL
.	NULL

Characterization	NULL
of	NULL
an	NULL
immediate-early	NULL
gene	NULL
induced	NULL
in	NULL
adherent	NULL
monocytes	NULL
that	NULL
encodes	NULL
I	NULL
«	NULL
B-like	NULL
activity	NULL
.	NULL

Cell	NULL
,	NULL
65	NULL
:	NULL
1281-1289	NULL
,	NULL
1991	NULL
.	NULL

26	NULL
.	NULL

Davis	NULL
,	NULL
N.	NULL
,	NULL
Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Simmons	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
,	NULL
Liou	NULL
,	NULL
H.	NULL
C.	NULL
,	NULL
Baltimore	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Bose	NULL
,	NULL
H.	NULL
R.	NULL
J.	NULL
Rel-associated	NULL
pp40	NULL
:	NULL
an	NULL
inhibitor	NULL
of	NULL
the	NULL
rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
253	NULL
:	NULL
1268-1271	NULL
,	NULL
1991	NULL
.	NULL

27	NULL
.	NULL

Ohno	NULL
,	NULL
I.	NULL
,	NULL
Takimoto	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
McKeithan	NULL
,	NULL
T.	NULL
W.	NULL
The	NULL
candidate	NULL
proto-oncogene	NULL
bcl-3	NULL
is	NULL
related	NULL
to	NULL
genes	NULL
implicated	NULL
in	NULL
cell	NULL
lineage	NULL
determination	NULL
and	NULL
cell	NULL
cycle	NULL
control	NULL
.	NULL

Cell	NULL
,	NULL
60	NULL
:	NULL
991-997	NULL
,	NULL
1990	NULL
.	NULL

Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
339	NULL
28	NULL
.	NULL

Wulezyn	NULL
,	NULL
F.	NULL
G.	NULL
,	NULL
Naumann	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Scheidereit	NULL
,	NULL
C.	NULL
Candidate	NULL
proto-oncogene	NULL
bel-3	NULL
encodes	NULL
a	NULL
subunit-specific	NULL
inhibitor	NULL
of	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
358	NULL
:	NULL
597-599	NULL
,	NULL
1992	NULL
.	NULL

29	NULL
.	NULL

Inoue	NULL
,	NULL
J.	NULL
,	NULL
Kerr	NULL
,	NULL
L.	NULL
D.	NULL
,	NULL
Kakizuka	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
IkBy	NULL
,	NULL
a	NULL
70	NULL
kd	NULL
protein	NULL
identical	NULL
to	NULL
the	NULL
C-terminal	NULL
half	NULL
of	NULL
p110	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
I	NULL
«	NULL
B	NULL
family	NULL
.	NULL

Cell	NULL
,	NULL
68	NULL
:	NULL
1109-1120	NULL
,	NULL
1992	NULL
.	NULL

30	NULL
.	NULL

Tewari	NULL
,	NULL
M.	NULL
,	NULL
Dobranski	NULL
,	NULL
P.	NULL
,	NULL
Mohn	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Cressman	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Hsu	NULL
,	NULL
J-C.	NULL
,	NULL
Bravo	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Taub	NULL
,	NULL
R.	NULL
Rapid	NULL
induction	NULL
in	NULL
regenerating	NULL
liver	NULL
of	NULL
RL/IF-1	NULL
(	NULL
an	NULL
IxB	NULL
that	NULL
inhibits	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
RelB-p50	NULL
,	NULL
and	NULL
c-Rel-p50	NULL
)	NULL
and	NULL
PHF	NULL
,	NULL
a	NULL
novel	NULL
«	NULL
B	NULL
site-binding	NULL
complex	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
12	NULL
:	NULL
2898-2908	NULL
,	NULL
1992	NULL
.	NULL

31	NULL
.	NULL

Kerr	NULL
,	NULL
L.	NULL
D.	NULL
,	NULL
Inoue	NULL
,	NULL
J.	NULL
,	NULL
Davis	NULL
,	NULL
N.	NULL
,	NULL
Link	NULL
,	NULL
E.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Bose	NULL
,	NULL
H.	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
The	NULL
rel-associated	NULL
pp40	NULL
protein	NULL
prevents	NULL
DNA	NULL
binding	NULL
of	NULL
Rel	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
relationship	NULL
with	NULL
IkBG	NULL
and	NULL
regulation	NULL
by	NULL
phosphorylation	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

,	NULL
5	NULL
:	NULL
1464-1476	NULL
,	NULL
1991	NULL
.	NULL

32	NULL
.	NULL

Fujita	NULL
,	NULL
T.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Ghosh	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
Independent	NULL
modes	NULL
of	NULL
transcriptional	NULL
activation	NULL
by	NULL
the	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

,	NULL
6	NULL
:	NULL
775-787	NULL
,	NULL
1992	NULL
.	NULL

33	NULL
.	NULL

Kunsch	NULL
,	NULL
C.	NULL
,	NULL
Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
and	NULL
Rosen	NULL
,	NULL
G.	NULL
A	NULL
.	NULL

Selection	NULL
of	NULL
optimal	NULL
«	NULL
B/	NULL
Rel	NULL
DNA-binding	NULL
motifs	NULL
:	NULL
interaction	NULL
of	NULL
both	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
with	NULL
DNA	NULL
is	NULL
required	NULL
for	NULL
transcriptional	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
12	NULL
;	NULL
4412-4421	NULL
,	NULL
1992	NULL
.	NULL

34	NULL
.	NULL

Perkins	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
Schmid	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Duckett	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
Leung	NULL
,	NULL
K.	NULL
,	NULL
Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
and	NULL
Nabel	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

Distinct	NULL
combinations	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
determine	NULL
the	NULL
specificity	NULL
of	NULL
transcriptional	NULL
activation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
89	NULL
;	NULL
1529-1533	NULL
,	NULL
1992	NULL
.	NULL

35	NULL
.	NULL

Mihm	NULL
,	NULL
S.	NULL
,	NULL
Ennen	NULL
,	NULL
J.	NULL
,	NULL
Pessara	NULL
,	NULL
U.	NULL
,	NULL
Kurth	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Droge	NULL
,	NULL
W.	NULL
Inhibition	NULL
of	NULL
HIV-1	NULL
replication	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
by	NULL
cysteine	NULL
and	NULL
cysteine	NULL
deriva-tives	NULL
.	NULL

AIDS	NULL
,	NULL
5	NULL
:	NULL
497-503	NULL
,	NULL
1991	NULL
.	NULL

36	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
Rieber	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
Reactive	NULL
oxygen	NULL
intermediates	NULL
as	NULL
apparently	NULL
widely	NULL
used	NULL
messengers	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
and	NULL
HIV-1	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
10	NULL
;	NULL
2247-2258	NULL
,	NULL
1991	NULL
.	NULL

37	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
Meier	NULL
,	NULL
B.	NULL
,	NULL
Mannel	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Droge	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
Dithiocarbamates	NULL
as	NULL
potent	NULL
inhibitors	NULL
of	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
intact	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
175	NULL
:	NULL
1181-1194	NULL
,	NULL
1992	NULL
.	NULL

38	NULL
.	NULL

Staal	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
Roederer	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Herzenberg	NULL
,	NULL
L.	NULL
A.	NULL
Intracellular	NULL
thiols	NULL
regulate	NULL
activation	NULL
of	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
and	NULL
transcription	NULL
of	NULL
human	NULL
im-munodeficiency	NULL
virus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
87	NULL
:	NULL
9943-9947	NULL
,	NULL
1990	NULL
.	NULL

39	NULL
.	NULL

Granelli-Piperno	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Nolan	NULL
,	NULL
P.	NULL
Nuclear	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
elements	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
:	NULL
induction	NULL
requirements	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
147	NULL
:	NULL
2734-2739	NULL
,	NULL
1991	NULL
.	NULL

40	NULL
.	NULL

Kang	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Tran	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Grilli	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
NF-	NULL
«	NULL
B	NULL
subunit	NULL
regulation	NULL
in	NULL
nontransformed	NULL
CD4+	NULL
T	NULL
lymphocytes	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
256	NULL
:	NULL
1452-1456	NULL
,	NULL
1992	NULL
.	NULL

41	NULL
.	NULL

Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
Tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
induces	NULL
proteins	NULL
that	NULL
bind	NULL
specifically	NULL
to	NULL
«	NULL
B-like	NULL
enhancer	NULL
elements	NULL
and	NULL
regulate	NULL
interleukin	NULL
2	NULL
receptor	NULL
a-chain	NULL
gene	NULL
expression	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
86	NULL
:	NULL
2331-2335	NULL
,	NULL
1989	NULL
.	NULL

42	NULL
.	NULL

Cerdan	NULL
,	NULL
C.	NULL
,	NULL
Razanajaona	NULL
,	NULL
D.	NULL
,	NULL
Martin	NULL
,	NULL
Y.	NULL
,	NULL
Courcoul	NULL
,	NULL
M.	NULL
,	NULL
Pavon	NULL
,	NULL
C.	NULL
,	NULL
Mawas	NULL
,	NULL
C.	NULL
,	NULL
Olive	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Birg	NULL
,	NULL
F.	NULL
Contributions	NULL
of	NULL
the	NULL
CD2	NULL
and	NULL
CD28	NULL
T	NULL
lymphocyte	NULL
activation	NULL
pathways	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
CSF-1	NULL
)	NULL
gene	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
149	NULL
;	NULL
373-379	NULL
,	NULL
1992.	NULL
,	NULL
43	NULL
.	NULL

Cerdan	NULL
,	NULL
C.	NULL
,	NULL
Martin	NULL
,	NULL
Y.	NULL
,	NULL
Brailly	NULL
,	NULL
H.	NULL
,	NULL
Courcoul	NULL
,	NULL
M.	NULL
,	NULL
Flavetta	NULL
,	NULL
S.	NULL
,	NULL
Costello	NULL
,	NULL
R.	NULL
,	NULL
Mawas	NULL
,	NULL
C.	NULL
,	NULL
Birg	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Olive	NULL
,	NULL
D.	NULL
IL-1a	NULL
is	NULL
produced	NULL
by	NULL
T	NULL
lymphocytes	NULL
activated	NULL
via	NULL
the	NULL
CD2	NULL
plus	NULL
CD28	NULL
pathways	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
146	NULL
:	NULL
560-564	NULL
,	NULL
1991	NULL
.	NULL

44	NULL
.	NULL

Rubin	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Kurman	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Fritz	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Biddison	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
Boutin	NULL
,	NULL
B.	NULL
,	NULL
Yarchoan	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Nelson	NULL
,	NULL
D.	NULL
L.	NULL
Soluble	NULL
interleukin	NULL
2	NULL
receptors	NULL
are	NULL
released	NULL
from	NULL
activated	NULL
human	NULL
lymphoid	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
135	NULL
:	NULL
3172-3177	NULL
,	NULL
1985	NULL
.	NULL

45	NULL
.	NULL

Rubin	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Jay	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Nelson	NULL
,	NULL
D.	NULL
L.	NULL
The	NULL
released	NULL
interleukin	NULL
2	NULL
receptor	NULL
binds	NULL
interleukin	NULL
2	NULL
efficiently	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
137	NULL
:	NULL
3841-3844	NULL
,	NULL
1986	NULL
.	NULL

46	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
Blank	NULL
,	NULL
V.	NULL
,	NULL
Logeat	NULL
,	NULL
F.	NULL
,	NULL
Vandekerckhove	NULL
,	NULL
J.	NULL
,	NULL
Lottspeich	NULL
,	NULL
F.	NULL
,	NULL
Le-Bail	NULL
,	NULL
O.	NULL
,	NULL
Urban	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
identical	NULL
to	NULL
factor	NULL
KBF1	NULL
and	NULL
homologous	NULL
to	NULL
the	NULL
rel	NULL
oncogene	NULL
product	NULL
.	NULL

Cell	NULL
,	NULL
62	NULL
:	NULL
1007-1018	NULL
,	NULL
1990	NULL
.	NULL

47	NULL
.	NULL

Brownell	NULL
,	NULL
E.	NULL
,	NULL
Ruscetti	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Smith	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
and	NULL
Rice	NULL
,	NULL
N.	NULL
R.	NULL
Detection	NULL
of	NULL
rel-related	NULL
RNA	NULL
and	NULL
protein	NULL
in	NULL
human	NULL
lymphoid	NULL
cells	NULL
.	NULL

Oncogene	NULL
,	NULL
3	NULL
:	NULL
93-98	NULL
,	NULL
1988	NULL
.	NULL

48	NULL
.	NULL

Adams	NULL
,	NULL
B.	NULL
S.	NULL
,	NULL
Leung	NULL
,	NULL
K.	NULL
Y.	NULL
,	NULL
Hanley	NULL
,	NULL
E.	NULL
W.	NULL
,	NULL
and	NULL
Nabel	NULL
,	NULL
G.	NULL
J.	NULL
Cloning	NULL
of	NULL
R	NULL
«	NULL
B	NULL
,	NULL
a	NULL
novel	NULL
DNA-binding	NULL
protein	NULL
that	NULL
recognizes	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
a	NULL
chain	NULL
xB	NULL
site	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

,	NULL
3	NULL
:	NULL
1063-1073	NULL
,	NULL
1991	NULL
.	NULL

49	NULL
.	NULL

Rice	NULL
,	NULL
G.	NULL
C.	NULL
,	NULL
Bump	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Shrieve	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
Lee	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Kovacs	NULL
,	NULL
M.	NULL
Quantitative	NULL
analysis	NULL
of	NULL
cellular	NULL
glutathione	NULL
by	NULL
flow	NULL
cytometry	NULL
utilizing	NULL
monochlorobimane	NULL
:	NULL
some	NULL
applications	NULL
to	NULL
radiation	NULL
and	NULL
drug	NULL
resistance	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
46	NULL
:	NULL
6105-6110	NULL
,	NULL
1986	NULL
.	NULL

50	NULL
.	NULL

Hwang	NULL
,	NULL
C.	NULL
,	NULL
Sinskey	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
and	NULL
Lodish	NULL
,	NULL
H.	NULL
F.	NULL
Oxidized	NULL
redox	NULL
state	NULL
of	NULL
glutathione	NULL
in	NULL
the	NULL
endoplasmic	NULL
reticulum	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
257	NULL
:	NULL
1496-1502	NULL
,	NULL
1992	NULL
.	NULL

51	NULL
.	NULL

Molitor	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
«	NULL
B-specific	NULL
DNA	NULL
binding	NULL
proteins	NULL
are	NULL
differentially	NULL
inhibited	NULL
by	NULL
enhancer	NULL
mutations	NULL
and	NULL
biological	NULL
oxidation	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

,	NULL
3	NULL
:	NULL
987-996	NULL
,	NULL
1991	NULL
.	NULL

52	NULL
.	NULL

Suthanthiran	NULL
,	NULL
M.	NULL
,	NULL
Anderson	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Sharma	NULL
,	NULL
V.	NULL
K.	NULL
,	NULL
and	NULL
Meister	NULL
,	NULL
A.	NULL
Glutathione	NULL
regulates	NULL
activation-dependent	NULL
DNA	NULL
synthesis	NULL
in	NULL
highly	NULL
purified	NULL
normal	NULL
human	NULL
T	NULL
lymphocytes	NULL
stimulated	NULL
via	NULL
the	NULL
CD2	NULL
and	NULL
CD3	NULL
antigens	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
87	NULL
:	NULL
3343-3347	NULL
,	NULL
1990	NULL
.	NULL

53	NULL
.	NULL

Hohmann	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
Remy	NULL
,	NULL
R.	NULL
,	NULL
Scheidereit	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
van	NULL
Loon	NULL
,	NULL
A.	NULL
P.	NULL
Maintenance	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
is	NULL
dependent	NULL
on	NULL
protein	NULL
synthesis	NULL
and	NULL
the	NULL
continuous	NULL
presence	NULL
of	NULL
external	NULL
stimuli	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
11	NULL
:	NULL
259-266	NULL
,	NULL
1991	NULL
.	NULL

54	NULL
.	NULL

Ten	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Paya	NULL
,	NULL
C.	NULL
V.	NULL
,	NULL
Israel	NULL
,	NULL
N.	NULL
,	NULL
Le-Bail	NULL
,	NULL
O.	NULL
,	NULL
Mattei	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Virelizier	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

The	NULL
characterization	NULL
of	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
indicates	NULL
that	NULL
it	NULL
participates	NULL
in	NULL
its	NULL
own	NULL
regulation	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
17	NULL
;	NULL
195-203	NULL
,	NULL
1992	NULL
.	NULL

55	NULL
.	NULL

Tan	NULL
,	NULL
T.	NULL
H.	NULL
,	NULL
Huang	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Sica	NULL
,	NULL
A.	NULL
,	NULL
Ghosh	NULL
,	NULL
P.	NULL
,	NULL
Young	NULL
,	NULL
H.	NULL
A.	NULL
,	NULL
Longo	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
and	NULL
Rice	NULL
,	NULL
N.	NULL
R.	NULL
«	NULL
B	NULL
site-dependent	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
a-chain	NULL
gene	NULL
promoter	NULL
by	NULL
human	NULL
c-Rel	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
12	NULL
:	NULL
4067-4075	NULL
,	NULL
1992	NULL
.	NULL

56	NULL
.	NULL

Burdach	NULL
,	NULL
S.	NULL
,	NULL
Zessack	NULL
,	NULL
N.	NULL
,	NULL
Dilloo	NULL
,	NULL
D.	NULL
,	NULL
Shatsky	NULL
,	NULL
M.	NULL
,	NULL
Thompson	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Levitt	NULL
,	NULL
L.	NULL
Differential	NULL
regulation	NULL
of	NULL
lymphokine	NULL
production	NULL
by	NULL
distinct	NULL
subunits	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
interleukin	NULL
2	NULL
receptor	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
87	NULL
:	NULL
2114-2121	NULL
,	NULL
1991	NULL
.	NULL

57	NULL
.	NULL

Kumar	NULL
,	NULL
S.	NULL
,	NULL
Rabson	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Gelinas	NULL
,	NULL
C.	NULL
The	NULL
RxxRxRxxC	NULL
motif	NULL
conserved	NULL
in	NULL
all	NULL
Rel/	NULL
«	NULL
B	NULL
proteins	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
DNA-binding	NULL
activity	NULL
and	NULL
redox	NULL
regulation	NULL
of	NULL
the	NULL
v-Rel	NULL
oncoprotein	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
12	NULL
:	NULL
3094-3106	NULL
,	NULL
1992	NULL
.	NULL

58	NULL
.	NULL

Olive	NULL
,	NULL
D.	NULL
,	NULL
Raymond	NULL
,	NULL
J.	NULL
,	NULL
Dubreuil	NULL
,	NULL
P.	NULL
,	NULL
Charmot	NULL
,	NULL
D.	NULL
,	NULL
Jacques	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Mawas	NULL
,	NULL
C.	NULL
Anti-interleukin	NULL
2	NULL
receptor	NULL
monoclonal	NULL
antibodies	NULL
:	NULL
respective	NULL
role	NULL
of	NULL
epitope	NULL
mapping	NULL
and	NULL
monoclonal	NULL
antibody-receptor	NULL
interactions	NULL
in	NULL
their	NULL
antagonist	NULL
effects	NULL
on	NULL
interleukin	NULL
2-dependent	NULL
T	NULL
cell	NULL
growth	NULL
.	NULL

Eur	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
16	NULL
;	NULL
611-616	NULL
,	NULL
1986	NULL
.	NULL

59	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Muller	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
``	NULL
mini-extracts	NULL
,	NULL
``	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
17	NULL
:	NULL
6419	NULL
,	NULL
1989	NULL
.	NULL

60	NULL
.	NULL

Bradford	NULL
,	NULL
M.	NULL
M.	NULL
A	NULL
rapid	NULL
and	NULL
sensitive	NULL
method	NULL
for	NULL
the	NULL
quantitation	NULL
of	NULL
microgram	NULL
quantities	NULL
of	NULL
protein	NULL
utilizing	NULL
the	NULL
principle	NULL
of	NULL
protein-dye	NULL
binding	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
72	NULL
:	NULL
248-254	NULL
,	NULL
1976	NULL
.	NULL

61	NULL
.	NULL

Kadonaga	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
Carner	NULL
,	NULL
K.	NULL
R.	NULL
,	NULL
Masiarz	NULL
,	NULL
F.	NULL
R.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
Isolation	NULL
of	NULL
cDNA	NULL
encoding	NULL
transcription	NULL
factors	NULL
SP1	NULL
and	NULL
functional	NULL
analysis	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

Cell	NULL
,	NULL
517	NULL
:	NULL
1079-1090	NULL
,	NULL
1987	NULL
.	NULL

62	NULL
.	NULL

Laemmli	NULL
,	NULL
U.	NULL
K.	NULL
Cleavage	NULL
of	NULL
structural	NULL
proteins	NULL
during	NULL
the	NULL
assembly	NULL
of	NULL
the	NULL
head	NULL
of	NULL
bacteriophage	NULL
T4	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
227	NULL
:	NULL
680-685	NULL
,	NULL
1970	NULL
.	NULL

